http://jnci.oxfordjournals.org/content/99/11/868.full
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Analysis of Integrin α7 Mutations in Prostate Cancer, Liver Cancer, Glioblastoma Multiforme, and Leiomyosarcoma </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/99/11/868" />
      <meta content="/jnci/99/11/868.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Analysis of Integrin α7 Mutations in Prostate Cancer, Liver Cancer, Glioblastoma Multiforme, and Leiomyosarcoma"
            name="DC.Title" />
      <meta content="10.1093/jnci/djk199" name="DC.Identifier" />
      <meta content="2007-06-06" name="DC.Date" />
      <meta content="Oxford University Press" name="DC.Publisher" />
      <meta content="Baoguo Ren" name="DC.Contributor" />
      <meta content="Yan P. Yu" name="DC.Contributor" />
      <meta content="George C. Tseng" name="DC.Contributor" />
      <meta content="Chuanyue Wu" name="DC.Contributor" />
      <meta content="Ka Chen" name="DC.Contributor" />
      <meta content="Uma N. Rao" name="DC.Contributor" />
      <meta content="Joel Nelson" name="DC.Contributor" />
      <meta content="George K. Michalopoulos" name="DC.Contributor" />
      <meta content="Jian-Hua Luo" name="DC.Contributor" />
      <meta content="Journal of the National Cancer Institute"
            name="citation_journal_title" />
      <meta content="JNCI J Natl Cancer Inst" name="citation_journal_abbrev" />
      <meta content="0027-8874" name="citation_issn" />
      <meta content="1460-2105" name="citation_issn" />
      <meta name="citation_author" content="Baoguo Ren" />
      <meta name="citation_author" content="Yan P. Yu" />
      <meta name="citation_author" content="George C. Tseng" />
      <meta name="citation_author" content="Chuanyue Wu" />
      <meta name="citation_author" content="Ka Chen" />
      <meta name="citation_author" content="Uma N. Rao" />
      <meta name="citation_author" content="Joel Nelson" />
      <meta name="citation_author" content="George K. Michalopoulos" />
      <meta name="citation_author" content="Jian-Hua Luo" />
      <meta content="Analysis of Integrin α7 Mutations in Prostate Cancer, Liver Cancer, Glioblastoma Multiforme, and Leiomyosarcoma"
            name="citation_title" />
      <meta content="99" name="citation_volume" />
      <meta content="11" name="citation_issue" />
      <meta content="868" name="citation_firstpage" />
      <meta content="880" name="citation_lastpage" />
      <meta content="99/11/868" name="citation_id" />
      <meta content="99/11/868" name="citation_id_from_sass_path" />
      <meta content="jnci;99/11/868" name="citation_mjid" />
      <meta content="10.1093/jnci/djk199" name="citation_doi" />
      <meta content="http://jnci.oxfordjournals.org/content/99/11/868.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/99/11/868.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/99/11/868.full.pdf"
            name="citation_pdf_url" />
      <meta content="/content/99/11.cover.gif" name="issue_cover_image" />
      <meta content="http://jnci.oxfordjournals.org/content/99/11/868"
            name="citation_public_url" />
      <meta content="17551147" name="citation_pmid" />
      <meta name="citation_access" content="all" />
      <meta name="citation_fulltext_world_readable" content="" />
      <meta name="citation_section" content="Article" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/99/11/858.short" rel="prev" />
      <link href="/content/99/11/881.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-ac.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" /><script type="text/javascript" id="session-d29600603e1">var callbackToken='537C0CF5831DD60';</script><script type="text/javascript" id="session-d29600603e3">
                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript">
            var gAuthTimeStamp = '2015-10-27T12:17:33.023-07:00';
            var gSessionId = 'xRJVs5AkOHu4GS6Ilzs1aw';
            var gAuthzRequired = 'false';
            var gAuthnMethods1 = 'ip ip';
            var gAuthnMethods2 = 'ip,ip';
            var gAuthnIPs = '18.189.59.169,18.189.59.169';
            var gAuthnIndividuals = '';
            var gAuthnInstitutions = '10005282,10072538,10328193,100274300,10082403,05094000,10093227,153074108,10080507,21879000,10095822,10081742,10082405,10004595,10019502,10082401,07635000,10082404,06602000';
            </script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-site.js"></script><script type="text/javascript" src="/local/js/local-js-vars.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-modalwin-vars.js"></script><script type="text/javascript"
              src="/publisher/js/hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-mathjax.js"></script><script type="text/x-mathjax-config">
          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
          MathJax.Hub.Queue(function() {
            gColTempResize = true;
            fixColHeights(1);
            gColTempResize = false;
          });
       </script><script type="text/javascript"
              src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><script type="text/javascript">
	    
	    
	    
	    var siqDOI = encodeURIComponent("10.1093/jnci/djk199");
	    var siqIsOpenAccess = encodeURIComponent("true");
	    var siqPubDate = encodeURIComponent("20070606");

	    if (siqDOI.length == 0) {
	        siqDOI = "UNKNOWN";
	    }
	    
	    
		
		
	    if (gAuthnIndividuals.length != 0) {
		if (gAuthnInstitutions.length != 0) {
		    authnEntity = encodeURIComponent(gAuthnIndividuals
		        + ',' + gAuthnInstitutions);
		} else {
		    authnEntity = encodeURIComponent(gAuthnIndividuals);
		}
	    } else {
	        authnEntity = encodeURIComponent(gAuthnInstitutions);
	    }

	    var commonString =
		'authSessionId=' + gSessionId + String.fromCharCode(0x26)
		+ 'authzRequired=' + gAuthzRequired + String.fromCharCode(0x26)
		+ 'authentication_method=' + encodeURIComponent(gAuthnMethods2) + String.fromCharCode(0x26)
		+ 'authnIPs=' + gAuthnIPs + String.fromCharCode(0x26)
		+ 'authnInstitutions=' + authnEntity;

		
		
		
		

	    var gPageId = "pageid-content";
	    var gVariant = "full-text";

	    
		// Not completely done
		var eventType = "full-text";
		var accessType;
		if (siqIsOpenAccess == 'true') {
		    accessType = 'SOA';
		} else {
		    accessType = 'subscription';
		}
		    
		var NTPT_PGEXTRA =
		    commonString + String.fromCharCode(0x26)
		    + 'event_type=' + eventType + String.fromCharCode(0x26)
		    + 'publication_date=' + siqPubDate + String.fromCharCode(0x26)
		    + 'access_type=' + accessType + String.fromCharCode(0x26)
		    + 'doi=' + siqDOI ;
		    
		

	    // alert("NTPT_PGEXTRA is " + NTPT_PGEXTRA);
	</script><link rel="stylesheet" type="text/css" media="all" href="/resource/css/hw20.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-header.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-footer.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-sidebars.css" />
      <link type="text/css" media="all" rel="stylesheet" href="/site/resource/jnci_h20.css" />
      <link rel="stylesheet" type="text/css" href="/resource/css/print.css" media="print" /><script type="text/javascript" src="/resource/js/main.js"></script><link rel="stylesheet" type="text/css" media="all"
            href="http://oi-underbar.ifactory.com/underbar/css/pf_oiunderbar.css" />
      <link rel="stylesheet" type="text/css" media="screen"
            href="http://gab.cookie.oup.com/aws-cookie/jquery.fancybox-1.3.4_1.css" /><script type="text/javascript" src="/resource/js/oup_ad_size.js"></script></head>
   <body class="general_page journal jnci">
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content"
           itemscope="itemscope"
           itemtype="http://schema.org/ScholarlyArticle">
         <noscript>
            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="JNCI J Natl Cancer Inst"><a href="/"><span>
                     JNCI J Natl Cancer Inst
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jnci/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jnci/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="/content/current"><span>View Current Issue (Volume 107 Issue 10 October 2015)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  MIT Libraries</li>
                     <li class="no-left-border">
                        <a href="/login?uri=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcontent%2F99%2F11%2F868.full">
                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/"
                     class="breadcrumb_subject">Medicine &amp; Health</a></span></li>
            <li><a href="/">JNCI J Natl Cancer Inst</a></li>
            <li><a href="/content/99/11.toc">
                  <span xmlns="" class="volume-value">Volume 99</span>
                  <span xmlns="" class="issue-value"> Issue 11</span></a></li>
            <li>Pp. <span class="slug-pages">
                  868-880.
                  </span></li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top"
                    src="/resource/htmlfiles/advert.html?p=Top&amp;u=jnci.oxfordjournals.org/content/99/11/868.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div id="content-block">
            <div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Analysis of Integrin α7 Mutations in Prostate Cancer, Liver Cancer, Glioblastoma Multiforme, and Leiomyosarcoma</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Baoguo+Ren&amp;sortspec=date&amp;submit=Submit">Baoguo Ren</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Yan+P.+Yu&amp;sortspec=date&amp;submit=Submit">Yan P. Yu</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=George+C.+Tseng&amp;sortspec=date&amp;submit=Submit">George C. Tseng</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-4" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Chuanyue+Wu&amp;sortspec=date&amp;submit=Submit">Chuanyue Wu</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-5" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="/search?author1=Ka+Chen&amp;sortspec=date&amp;submit=Submit">Ka Chen</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-6" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Uma+N.+Rao&amp;sortspec=date&amp;submit=Submit">Uma N. Rao</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-7" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Joel+Nelson&amp;sortspec=date&amp;submit=Submit">Joel Nelson</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-8" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=George+K.+Michalopoulos&amp;sortspec=date&amp;submit=Submit">George K. Michalopoulos</a></span> and 
                     </li>
                     <li class="last" id="contrib-9"><span class="name"><a class="name-search"
                              href="/search?author1=Jian-Hua+Luo&amp;sortspec=date&amp;submit=Submit">Jian-Hua Luo</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address><strong>Affiliations of authors:</strong> Departments of Pathology (BR, YPY, CW, KC, UNR, GKM, JHL), Biostatistics (GCT), and Urology (JN), University of Pittsburgh,
                           Pittsburgh, PA
                        </address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="fn" id="corresp-1"><strong>Correspondence to:</strong><br /> Jian-Hua Luo, MD, PhD, 3550 Terrace St, Scaife Hall A-725, Pittsburgh, PA 15261 (e-mail: <span class="em-link"><span class="em-addr">luoj{at}msx.upmc.edu</span></span>).
                     </li>
                  </ol>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                         hwp:start="2006-11-09"><span class="received-label">Received </span>November 9, 2006.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd"
                         hwp:start="2007-03-23"><span class="rev-recd-label">Revision received </span>March 23, 2007.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                         hwp:start="2007-04-20"><span class="accepted-label">Accepted </span>April 20, 2007.
                     </li>
                  </ul>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#sec-11" title="Patients, Materials, and Methods"
                        class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  <div id="sec-1" class="subsection">
                     <p id="p-2"><strong>Background</strong> Integrins are the major adhesive molecules in mammalian cells. Each integrin subtype plays a unique role in cell differentiation
                        and embryo development. However, integrin involvement in carcinogenesis has not been well defined.
                     </p>
                  </div>
                  <div id="sec-2" class="subsection">
                     <p id="p-3"><strong>Methods</strong> We identified mutations in integrin α7 by sequencing genomic DNAs and cDNAs from 122 specimens, including 62 primary human
                        tumor samples, four cell lines, and 56 matched normal tissues. We evaluated the tumor suppressor activity of integrin α7 with
                        colony formation, soft agar colony growth, and cell migration assays by forcing its expression in PC-3 and Du145 prostate
                        cancer cells and SK-UT-1 leiomyosarcoma cells. PC-3 and Du145 xenograft tumors with increased levels of integrin α7 in severe
                        combined immune deficient mice were used to assess the effect of integrin α7 on tumor growth and metastasis. Immunostaining
                        was used to localize and to measure the level of integrin α7 in 701 and 141 specimens of prostate and smooth muscle, respectively.
                        A meta-analysis of integrin α7 mRNA microarray data from four studies was performed. Kaplan–Meier analyses were used to assess
                        survival. All statistical tests were two-sided.
                     </p>
                  </div>
                  <div id="sec-3" class="subsection">
                     <p id="p-4"><strong>Results</strong> Integrin α7 mutations that generate truncations were found in specimens of 16 of 28 prostate cancers (57%, 95% confidence
                        interval [CI] = 37% to 76%), five of 24 hepatocellular carcinomas (21%, 95% CI = 7% to 42%), five of six glioblastomas multiforme
                        (83%, 95% CI = 36% to 99%), and one of four leiomyosarcomas (25%, 95% CI = 0.6% to 81%). Integrin α7 mutations were associated
                        with increased recurrence of human prostate cancer (nine recurrences among 13 patients with integrin α7 mutations versus one
                        among eight without such mutations; odds ratio [OR] = 14, 95% CI = 1.15 to 782, <em>P</em> = .024) and hepatocellular carcinoma (five recurrences among eight patients with integrin α7 mutations versus one among 16
                        without such mutations, OR = 21, 95% CI = 1.6 to 1245; <em>P</em> = .007). Forced expression of normal integrin α7 in prostate cancer and leiomyosarcoma cell lines suppressed tumor growth
                        and metastasis both in vitro and in vivo. Focal or no integrin α7 expression in human prostate cancer and soft tissue leiomyosarcoma
                        was associated with a reduction of metastasis-free survival (for example, for prostate cancer with focal or no expression,
                        5-year metastasis-free survival was 32%, 95% CI = 24.4% to 40.3%, and for prostate cancer with at least weak expression, it
                        was 85%, 95% CI = 79% to 91%; <em>P</em>&lt;.001). Microarray analysis indicated that cyclin D kinase inhibitor 3 and GTPase-activating protein may be possible targets
                        for integrin α7–mediated tumor suppressor activity and inhibition of cell motility.
                     </p>
                  </div>
                  <div id="sec-4" class="subsection">
                     <p id="p-5"><strong>Conclusion</strong> Integrin α7 appears to be a tumor suppressor that operates by suppressing tumor growth and retarding migration.
                     </p>
                  </div>
               </div>
               <p id="p-6">
                  <div class="boxed-text" id="boxed-text-1">
                     <div id="sec-5" class="subsection">
                        <h4>CONTEXT AND CAVEATS</h4>
                        <div id="sec-6" class="subsection">
                           <h5>Prior knowledge</h5>
                           <p id="p-7">Integrin α7 forms a dimmer with integrin β1 in plasma membranes and is responsible for communication between the extracellular
                              matrix and muscle cells, but the involvement of integrin α7 in carcinogenesis has not been well defined.
                           </p>
                        </div>
                        <div id="sec-7" class="subsection">
                           <h5>Study design</h5>
                           <p id="p-8">Molecular, cellular, human tumor specimen, and human xenograft tumor studies of integrin α7 to investigate the activity of
                              integrin α7 on tumor growth suppression and cell migration, as well as survival analyses of patients with prostate or hepatocellular
                              carcinomas and of mice bearing xenograft tumors.
                           </p>
                        </div>
                        <div id="sec-8" class="subsection">
                           <h5>Contribution</h5>
                           <p id="p-9">Integrin α7 truncation mutations were found in various types of human cancer specimens at various locations in the protein.
                              These mutations were associated with an increased risk of recurrence of human prostate cancers and hepatocellular carcinomas.
                              Forced expression of integrin α7 in tumor cells suppressed tumor growth and metastasis in vivo and in vitro. Possible targets
                              for integrin α7–mediated tumor suppressor activities include cyclin D kinase inhibitor 3 and GTPase-activating protein.
                           </p>
                        </div>
                        <div id="sec-9" class="subsection">
                           <h5>Implications</h5>
                           <p id="p-10">Impairing the function of integrin α7 may be an efficient mechanism of carcinogenesis.</p>
                        </div>
                        <div id="sec-10" class="subsection">
                           <h5>Limitations</h5>
                           <p id="p-11">The signaling pathway used by integrin α7 has not been identified. Other integrin α and β types, in addition to integrins
                              α7 and β1, may be present in various cells, which could alter integrin signaling homeostasis and thus cell growth.
                           </p>
                        </div>
                     </div>
                  </div>
               </p>
               <p id="p-12">As a major class of adhesive molecules in mammalian cells, the integrins are involved in many cellular processes, including
                  development, immune responses, leukocyte traffic, and hemostasis (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>). Integrin knockout mice have distinctive developmental defects, including kidney tubule defects, severe skin blistering,
                  chylothorax, and muscular dystrophy (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>–<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>). The integrin superfamily contains 24 members, each of which mediates a unique function in mammals. For example, integrins
                  α3, α6, or α7 combine with a β1 subunit to form receptors for laminin; and the combination of a β1 subunit with α1, α2, α10,
                  or α11 forms a receptor for collagen; heterodimers between β2 and αL, αM, αX, or αD form leukocyte-specific receptors; and
                  heterodimers between αV and several β subunits form the RGD tripeptide receptor. Regulation of integrin expression is critical
                  for certain aspects of tissue differentiation and regeneration [e.g., keratinocyte differentiation, hair follicle formation,
                  and skeletal muscle development (<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>–<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>)], and abnormal integrin expression is associated with several human diseases [e.g., muscular dystrophy, Glanzmann thrombasthenia,
                  and congenital cardiac myopathy (<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a>–<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>)]. Integrin α7 is thought to be involved in smooth and skeletal muscle development (<a id="xref-ref-10-3" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>). Very little is known about the role of integrin α7 in other tissues and organs.
               </p>
               <p id="p-13">Integrin α7 forms a heterodimer with integrin β1 in the plasma membrane and is responsible for communication between extracellular
                  matrix and muscle cells (<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>). There are two distinct isoforms of integrin α7 that are generated by two mutually exclusive alternative splicings. Whether
                  integrin α7 has a role in the development of cancer is largely unknown. However, the expression of integrin α7 has been shown
                  to be altered in some malignances [e.g., human leiomyosarcoma and prostate cancer (<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>–<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>)]. To investigate the role of integrin α7 in human malignancies, we examined whether this gene is mutated in specimens of
                  various human cancers, the level of integrin α7 expression is associated with clinical relapse of human malignancies, and
                  integrin α7 has tumor suppressor activity.
               </p>
               <div class="section" id="sec-11">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-26" title="Results" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Patients, Materials, and Methods</h2>
                  <div id="sec-12" class="subsection">
                     <h3>Cells, Culture Conditions, and Antibodies</h3>
                     <p id="p-14">All cell lines, including PC-3 (prostate cancer), Du145 (prostate cancer), LNCaP (prostate cancer), SK-UT-1 (leiomyosarcoma),
                        H1299 (lung cancer), and H358 (lung cancer), were purchased from American Type Cell Culture (Manassas, VA). PC-3 cells were
                        cultured with F12K medium supplemented with 10% fetal bovine serum (InVitrogen, Carlsbad, CA). Du145 and SK-UT-1 cells were
                        cultured with modified Eagle medium supplemented with 10% fetal bovine serum (InVitrogen). LNCaP, H358, and H1299 cells were
                        cultured with RPMI-1640 medium supplemented with 10% fetal bovine serum (InVitrogen). The 1573 cells, a renal cell carcinoma
                        cell line, were cultured with modified Eagle medium supplemented with 10% fetal bovine serum (InVitrogen). SW-33, SW39, SW40,
                        SW61, SW94, and SW95 (glioblastoma multiformes) were obtained from University of Pittsburgh Hillman Cancer Center and cultured
                        in modified Eagle medium supplemented with 10% fetal bovine serum (InVitrogen).
                     </p>
                     <p id="p-15">Rabbit anti–integrin α7 serum (polyclonal) was raised through immunization of a rabbit with the synthetic peptide GTILRNNWGSPRREGPDAH.
                        Mouse anti–integrin α7 monoclonal antibody was purchased from Novus Biologicals Inc (Littleton, CO). Mouse anti–cyclin D kinase
                        inhibitor 3 (CDKN3) monoclonal antibody was purchased from Abnova Corp (Taipei, Taiwan). Goat anti–GTPase-activating protein
                        (RACGAP1) antibody (polyclonal) was purchased from Abcam (Cambridge, MA). Goat anti–integrin β1 (polyclonal) and mouse anti–β-actin
                        monoclonal antibodies were purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, CA).
                     </p>
                  </div>
                  <div id="sec-13" class="subsection">
                     <h3>Human Cancer Patients and Specimens</h3>
                     <p id="p-16">The prostate cancer specimens that were analyzed had been archived as frozen or formalin-fixed paraffin-embedded specimens
                        of tissues from radical prostatectomies from 1985 through 2000. Specimens were selected largely on the basis of their availability
                        or whether sufficient amounts of tumor tissues were present. The ages of patients at the time of surgery ranged from 45 through
                        79 years. In total, 435 samples were collected. Two hundred ninety-four of the 435 corresponding patients were followed clinically
                        for at least 5 years. Hepatocellular carcinoma specimens were analyzed that had been archived as frozen specimens of liver
                        tissue resections from 1997 through 2002. In total, 24 specimens were collected, and the corresponding patients were followed
                        clinically for at least 5 years. Soft tissue leimyosarcomas were analyzed that had been archived as frozen or formalin-fixed
                        paraffin-embedded specimens of tumor tissue resections from 1970 through 2000. One hundred eleven samples were collected.
                        Sixty-four of the 111 corresponding patients were followed clinically for at least 5 years. Six glioblastoma multiforme specimens
                        were analyzed that had been archived as frozen specimens of tissue resections from 1998 through 2002. Four separate study
                        protocols, all of which included informed consent exemptions, were approved by institutional review board.
                     </p>
                  </div>
                  <div id="sec-14" class="subsection">
                     <h3>Tissue Sample Preparation</h3>
                     <p id="p-17">Pure tumor specimens were obtained by dissecting freshly resected tissues, typically within 30 minutes of removal from patients.
                        These tissues were frozen at −80 °C and were selected on the basis of tissue availability. Tissues were retrieved and microdissected
                        immediately before the extraction of DNA or total RNA. Tumor cells were microdissected from frozen sections on slides by board-certified
                        pathologists (J.-H. Luo and G. K. Michalopoulos). For matched normal samples, different tissue lineages from the tumor or
                        blood cells (e.g., fat, blood vessels, and seminal vesicles) were obtained. Protocols for tissue banking (which was used for
                        pathology), deidentification, and processing (for molecular analyses) were approved by the institutional review board. The
                        study protocols were exempted from informed consent.
                     </p>
                  </div>
                  <div id="sec-15" class="subsection">
                     <h3>Sequencing Integrin α7 Genomic DNA and cDNA</h3>
                     <p id="p-18">Genomic DNA and total RNA were extracted from various tissues (i.e., prostate, liver, leiomyosarcoma, and glioblastoma multiforme)
                        by use of a QiAmp blood kit and a RNeasy kit from Qiagen (Valencia, CA), respectively, according to the manufacturer's instructions.
                        Five micrograms of total RNA was used for first-strand cDNA synthesis with d(T)<sub>24</sub> primer and Superscript II reverse transcriptase (200 U; GIBCO-BRL, Rockville, MD). Second-strand cDNA synthesis was carried
                        out at 16 °C by adding <em>Escherichia coli</em> DNA ligase (10 U), <em>E. coli</em> DNA polymerase I (40 U), and RNAse H (2 U) to the reaction mixture. T4 DNA polymerase (10 U in 20 μL) was added to blunt
                        the ends of newly synthesized cDNA, and the cDNA was purified by phenol–chloroform extraction and ethanol precipitation. Purified
                        genomic DNA or cDNA from various tissues served as templates for polymerase chain reactions (PCRs) that used a total of 31
                        sets of primers (Supplementary Table 1, available online) corresponding to the 27 exons of integrin α7. Each PCR product was
                        gel purified by use of the Geneclean purification kit (Qbiogene, Irvine, CA) and then sequenced by use of the corresponding
                        primers as described below. For cDNA sequencing, purified total RNA from various tissues was reverse transcribed with random
                        hexamers (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>) for double-stranded cDNA synthesis. PCR mixtures contained the cDNA templates and six sets of primers (Supplementary Table
                        1, available online) distributed along the entire integrin α7–coding region. Automated sequencing of all PCR products used
                        500 ng of DNA and the BigDye terminator 1.1 cycle sequencing kit (ABI, Foster City, CA), as described by the manufacturer.
                        The fluorescence-labeled PCR products were separated by electrophoresis in 6% polyacrylamide gels and analyzed with an ABI
                        Prism 377 DNA sequencer. When a mutation was identified in a genomic sample, cDNAs were prepared from the corresponding tissue,
                        and the entire integrin α7 coding region was sequenced as described above. Mutations in alleles were determined by clonal
                        sequencing of PCR products (cDNA or genome DNA) by use of primers encompassing the region of both mutations. Loss of heterogeneity
                        was determined by comparing single-nucleotide polymorphisms in the introns or exons of integrin α7 between matched normal
                        and tumor samples. For reverse transcription–PCR (RT–PCR) analysis of integrin α7 expression, the cDNAs from 16 cell lines
                        (including PC3, Du145, LNCaP, H23, H522, H358, H1299, SK-UT-1, Hep3G, 1573, SW-33, SW39, SW40, SW61, SW94, and SW95) were
                        synthesized as described above. cDNAs from 20 organs (including bone marrow, cerebellum, fetal brain, fetal liver, heart,
                        kidney, lung, placenta, prostate, salivary gland, skeletal muscle, spleen, testis, thyroid, trachea, uterus, colon, small
                        intestine, spinal cord, and stomach) were obtained from Clontech (Mountain View, CA). PCRs were performed with primers specific
                        for integrin α7 (Supplementary Table 1, available online).
                     </p>
                  </div>
                  <div id="sec-16" class="subsection">
                     <h3>Peptide Antibodies Against Integrin α7</h3>
                     <p id="p-19">The peptide GTILRNNWGSPRREGPDAH, which corresponds to amino acids 1097–1115 of human integrin α7, was chemically synthesized
                        and purified by high-pressure liquid chromatography at the University of Pittsburgh biotechnology support center. Rabbit antiserum
                        against this peptide was raised by Cocalico Biologicals, Inc (Reamstown, PA). Antibodies against integrin α7 were purified
                        by use of the synthetic peptide and a Carboxylink kit from Pierce (Rockford, IL). The specificity of rabbit preimmune serum
                        and anti–integrin α7 antiserum was tested on immunoblots of PC-3 and 1573 cell protein extracts. Integrin α7 bands were specifically
                        detected in extracts from both 1573 and PC-3 cells with anti–integrin α7 antiserum and with a monoclonal antibody against
                        integrin α7 (a positive control), but no visible integrin α7 band was detected with either preimmune serum or antiserum depleted
                        of integrin α7 peptide antibodies (see Supplementary Fig. 1, A; available online).
                     </p>
                  </div>
                  <div id="sec-17" class="subsection">
                     <h3>Immunohistochemistry and Tissue Array Analysis</h3>
                     <p id="p-20">For tissue microarray analysis, 701 formalin-fixed and paraffin-embedded prostate tissue specimens (407 from prostate cancer
                        tissue and 294 from normal prostate tissue as described above) were arrayed onto six slides, with one or two samples from
                        each specimen (<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>). Patients in this group ranged in age from 45 to 79 years, and complete 5-year follow-up data was available for 266 patients
                        with prostate cancer (University of Pittsburgh Medical Center tissue collection archive, 1985 through 2000). Tissue array
                        slides and thin sections of paraffin-embedded tissues were used to study soft tissue leiomyosarcoma specimens (34 normal tissue
                        samples and 107 leiomyosarcomas, including samples from 60 patients with &gt;5 years of follow-up). These specimens were arrayed
                        onto three slides, with two samples from each specimen. Immunohistochemistry was performed as described previously (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>) with purified integrin α7 peptide antiserum (1:1000 dilution). The peptide antibody was omitted in negative controls. The
                        sections were then incubated with horseradish peroxidase–conjugated anti-rabbit IgG for 30 minutes at room temperature. Slides
                        were exposed to a 3,3′-diaminobenzidine solution to visualize immunostaining. Integrin α7 immunostaining was graded on a scale
                        of 0–3 as follows: 0 = no expression; 0.5 = focal positive; 1 = weak; 2 = moderate; 3 = strong. A threshold of score of 0.5
                        was used to determine the likelihood of tumor relapse, and it was chosen so that two groups had balanced sample sizes. Moving
                        the threshold to 0 or 1 resulted in a similar conclusion (data not shown).
                     </p>
                     <p id="p-21">To construct the inducible integrin α7 expression vector pCDNA4-ITGA7, full-length integrin α7 cDNA was ligated at the NotI
                        and KpnI sites of pcDNA4/TO/MYC/HIS-B (Invitrogen, CA). This plasmid was then cotransfected into PC-3 cells with pCDNA6/TR,
                        which encodes the tetracycline repressor. Transfected cells were selected by use of zeomycin (pCDNA4/TO/MYC/HIS-B–transfected
                        cells) and blasticidin S (pCDNA6/TR-transfected cells) (Invitrogen). Selected clonal cell lines, including two that were designated
                        PITT1 and PITT2, were tested for doxycycline inducibility (1 μg/mL) by western blot analysis with antibodies specific for
                        integrin α7 or β-actin (the loading control) and by immunofluorescence analysis (Supplementary Fig. 1, B; available online).
                        Coimmunoprecipitations using anti–integrin α7 antibodies indicated that integrin α7 and integrin β1 formed a protein complex
                        because immunoprecipitates contained integrin β1 protein (Supplementary Fig. 1, C; available online).
                     </p>
                  </div>
                  <div id="sec-18" class="subsection">
                     <h3>Immunofluorescence Localization of Integrin α7</h3>
                     <p id="p-22">PITT1 cells, in which integrin α7 expression can be induced by treatment with tetracycline at 1 μg/mL, were used for these
                        experiments. Cells were grown on covered slides in the presence of tetracycline, fixed with 3% paraformaldehyde, and then
                        blocked with normal donkey serum for 30 minutes at 4 °C. Anti-ITGA7 serum or preimmune rabbit serum (as the control) was added,
                        and slides were incubated for 1 hour at 4 °C. After three washes with phosphate-buffered saline (PBS), rhodamine-conjugated
                        donkey anti-rabbit secondary antibodies were added and incubated for 1 hour at 4 °C. After three washes with PBS, immunofluorescence
                        staining was visualized under an Olympus fluorescence inverted microscope IX (B &amp; B Microscopes, Ltd, Pittsburg, PA) (Supplementary
                        Fig. 1, B; available online).
                     </p>
                  </div>
                  <div id="sec-19" class="subsection">
                     <h3>Immunoblot Analysis of Integrin α7, Cyclin D Kinase Inhibitor 3, Rac GTPase-Activating Protein 1, and β-Actin</h3>
                     <p id="p-23">Integrin α7 expression was examined in PC3, DU145, 1573, SK-UT-1, H1299, and H358 cells. First, cells were washed with PBS
                        and lysed by RIPA buffer (50 mM Tris–HCl at pH 7.4, 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1
                        mM phenylmethylsulfonyl fluoride, aprotinin at 1 μg/mL, leupeptin at 1 μg/mL, pepstatin at 1 μg/mL, and 1 mM Na<sub>3</sub>VO<sub>4</sub>). The lysates were sonicated and centrifuged at 12000<em>g</em> at 4 °C for 30 minutes to remove the insoluble materials. The proteins were separated by sodium dodecyl sulfate–polyacrylamide
                        gel electrophoresis (SDS–PAGE) in 8.5% polyacrylamide gels, and bands were blotted onto a polyvinylidene difluoride membrane.
                        The membrane was blocked with 5% powdered skim milk in Tris–Tween 20 buffer (0.1 M Tris–HCl and 0.1% Tween-20 [pH 7.4]) for
                        1 hour at room temperature, followed by a 2-hour incubation with primary anti-ITGA7 antibodies (1:1000 dilution), anti-CDKN3
                        antibodies (1:1000 dilution; Abnova Corp), or anti-RACGAP1 antibodies (1:500 dilution; Abcam). The membrane was then washed
                        three times with Tris–Tween 20 buffer and incubated with a horseradish peroxidase–conjugated secondary antibody specific for
                        rabbit (anti-ITGA7, 1:1000 dilution), mouse (anti-CDKN3, 1:1000 dilution), or goat (anti-RACGAP1, 1:1000 dilution) for 1 hour
                        at room temperature. The protein expression was detected with the ECL system (Amersham, Life Science, Piscataway, NJ) according
                        to the manufacturer's protocols.
                     </p>
                  </div>
                  <div id="sec-20" class="subsection">
                     <h3>Colony Formation, Soft Agar Anchorage–Independent, and Wound-Healing Assays</h3>
                     <p id="p-24">Colony formation and soft agar anchorage–independent assays were similar to those previously described (<a id="xref-ref-20-2" class="xref-bibr" href="#ref-20">20</a>). PC-3, Du145, and SK-UT-1 cells that were transfected with pCMVscript or pCMV-integrin α7 and H1299 and H358 cells that
                        were transfected with pENTR-siITGA7 were used. For colony formation assay, 5000 cells were cultured in 60-mm dishes. Triplicate
                        experiments were performed for each cell clones. Medium was changed every 4 days. On the 10th day, the plates were stained
                        with 1% crystal violet, and colonies with diameter of more than 2 mm were counted.
                     </p>
                     <p id="p-25">For the soft agar colony formation assay, the same cell lines were used. In brief, 5000 cells were cultured on a plate containing
                        2% base agar and 0.43% top agar in the medium described above and incubated at 37 °C for 21 days. Plates were stained with
                        0.005% crystal violet for 1 hour. Colonies were counted by use of a dissecting microscope.
                     </p>
                     <p id="p-26">For the wound-healing assay (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>), Du145, PC-3, or SK-UT-1 cells were cultured in six-well culture plates in the medium described above. After cells reached
                        confluence, a plastic pipette tip was drawn across the center of the well to produce a clean crevice that was 1 mm wide. Microscopic
                        images of the “wounds” were taken in five different areas for each experiment (at an original magnification of ×10 with an
                        Olympus inverted system microscope IX). After culturing for 24 hours at 37 °C in F12K medium (PC-3 cells) or modified Eagle
                        medium (Du145 and SK-UT-1 cells) containing 10% fetal bovine serum, images of original locations were taken again, and recovered
                        areas (i.e., the bare area into which cells migrated) were measured as a percentage of the original wound.
                     </p>
                  </div>
                  <div id="sec-21" class="subsection">
                     <h3>Construction of Integrin α7–Expressing Cell Lines and Small Interfering RNA Vectors</h3>
                     <p id="p-27">Integrin α7 cDNA was generated from total RNA from normal donor prostate tissue by extended long PCR (<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">20</a>) with primers specific for the 5′ and 3′ ends of integrin α7. The 3.7-kilobase PCR product was ligated into a TA cloning
                        vector (Invitrogen) and from there cloned into a pCMVscript vector (Clontech) with <em>Hin</em>dIII and <em>Xho</em>I (New England Biolab, Ipswich, MA). The final pCMV-ITGA7 construct was sequenced by the automatic sequencing method, as described
                        above, to confirm that no mutations had been introduced. This construct was transfected into Du145, PC-3, or SK-UT-1 cells.
                        Colonies containing pCMV-ITGA7 were selected for with medium that included G418 (400 μg/mL).
                     </p>
                     <p id="p-28">To construct the small interfering RNA (siRNA) vectors for CDKN3, RACGAP1, integrin α7, and a scrambled control sequence,
                        oligonucleotides corresponding to the following regions of CDKN3 mRNA (5′-CACCGGAGCTTACAACCTGCCTTAAATTGATATCCGTTTAAGGCAGGTTGTAAGCTC-3′/5′-AAAAGAGCTTACAACCTGCCTTAAACGGATATCAATTTAAGGCAGGTTGTAAGCTCC-3′),
                        RACGAP1 (5′-CACCGTTTGCACTTTGGATGCTGAAATTGATATCCGTTTCAGCATCCAAAGTGCAAA-3′/5′-AAAATTTGCACTTTGGATGCTGAAACGGATATCAATTTCAGCATCCAAAGTGCAAAC-3′),
                        integrin α7 (5′-CACCGACTCCCAACCACTGGTTCTCCTTGCCGAAGCAAGGAGAACCAGTGGTTGGGAGT-3′/5′-AAAAACTCCCAACCACTGGTTCTCCTTGCTTCGGCAAGGAGAACCAGTGGTTGGGAGTC-3′),
                        or scrambled siRNA (5′-CACCGTAATGTATTGGAACGCATATTTTGATATCCGAATATGCGTTCCAATACATTA-3′/5′-AAAATAATGTATTGGAACGCATATTCGGATATCAAAATATGCGTTCCAATACATTA-3′)
                        were annealed and ligated into a pENTR/U6 vector. The ligated products were transfected into <em>E. coli</em> and plated on kanamycin plates (50 μg/mL). Six colonies per transfection were picked and sequenced for the presence of inserts.
                        The selected clones, which suppress the expression of integrin α7 (ITGA7), CDKN3, or RACGAP1, respectively, were then transfected
                        into cultured cells to generate pENTR-siITGA7–transfected H1299 or H358 cells or pENTR-siCDKN3– and pENTR-siRACGAP1–transfected
                        PITT1 and PITT2 cells.
                     </p>
                  </div>
                  <div id="sec-22" class="subsection">
                     <h3>Coimmunoprecipitation</h3>
                     <p id="p-29">We investigated the possibility that overexpression of integrin α7 could abrogate formation of the α7β1 heterodimer by use
                        of protein extracts that were obtained as described above. Protein extracts that were prepared from PITT1 cells that had been
                        induced with tetracycline to express integrin α7 were incubated with anti-ITGA7 antibody for 16 hours and then with protein
                        G-Sepharose beads for 3 hours to immunoprecipitate integrin α7 complex. The complex was washed five times with RIPA buffer,
                        and the bound proteins were eluted from the beads with SDS–PAGE sample buffer. The precipitated complexes were separated by
                        SDS–PAGE, electroblotted to a polyvinylidene difluoride membrane, and immunoblotted with anti-integrin β1 antibodies (1:500
                        dilution, Santa Cruz Biotechnology, Inc; Supplementary Fig. 1, C; available online). The membrane was then washed three times
                        with Tris–Tween 20 buffer and incubated with a horseradish peroxidase–conjugated secondary antibody specific for goat antibodies
                        (1:1000 dilution) for 1 hour at room temperature. The coimmunoprecipitated integrin β1 was detected with the ECL system (Amersham
                        Life Science), according to the manufacturer's protocols.
                     </p>
                  </div>
                  <div id="sec-23" class="subsection">
                     <h3>Tumor Growth and Spontaneous Metastasis</h3>
                     <p id="p-30">Approximately 1 × 10<sup>7</sup> viable PC-3 and Du145 cells, suspended in 0.2 mL of Hanks’ balanced salt solution (Krackeler Scientific, Inc, Albany, NY)
                        were subcutaneously implanted in the abdominal flanks of 48 severe combined immune deficient (SCID) mice to generate one tumor
                        per mouse. Mice were observed daily, and their body weight, tumor size, and lymph-node enlargement were recorded weekly. Tumor
                        and lymph node size were measured on the diameter. After 6 weeks or when mice became moribund, which ever occurred first,
                        mice were killed, and necropsies were performed. Serial sections of formalin-fixed, paraffin-embedded lung, brain, liver,
                        kidney, vertebra, and lymph node specimens were collected, stained with hematoxylin and eosin, and examined microscopically.
                        All animal procedures were approved by the University of Pittsburgh Institutional Animal Care and Use Committee.
                     </p>
                  </div>
                  <div id="sec-24" class="subsection">
                     <h3>mRNA Microarray Analysis</h3>
                     <p id="p-31">Total RNA was extracted from uninduced and induced PITT1 cells and purified with Qiagen RNeasy kit (Qiagen). Five micrograms
                        of total RNA was used for first-strand cDNA synthesis with T7-d(T)<sub>24</sub> primer [GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG-(dT)<sub>24</sub>] and Superscript II reverse transcriptase (200 U; GIBCO-BRL). Second-strand cDNA synthesis was carried out at 16 °C by adding
                        <em>E. coli</em> DNA ligase (10 U), <em>E. coli</em> DNA polymerase I (40 U), and RNAse H (2 U) to the reaction mixture. T4 DNA polymerase (10 U in 20 μL) was added to blunt
                        the ends of newly synthesized cDNA, and the cDNA was purified by phenol–chloroform extraction and ethanol precipitation. Purified
                        cDNAs were then incubated at 37 °C for 4 hours in an in vitro transcription reaction mixture containing 10 mM ATP, 10 mM biotin–CTP,
                        10 mM GTP, and 10 mM biotin–UTP to produce biotin-labeled complementary RNA (cRNA) by use of the MEGAscript system (Ambion,
                        Inc, Austin, TX). cRNA (15–20 μg) was fragmented by incubating in a buffer containing 200 mM Tris–acetate (pH 8.1), 500 mM
                        potassium acetate, and 150 mM magnesium acetate at 95 °C for 35 minutes. The fragmented RNA was then hybridized to a preequilibrated
                        Affymetrix chip (u133 2.0) at 45 °C for 14–16 hours. After the hybridization buffer was removed, the chips were washed in
                        a fluidic station with a low stringency buffer (6× SSPE [5.25% NaCl, 0.83% sodium phosphate, and 0.22% EDTA], 0.01% Tween-20,
                        and 0.005% antifoam) for 10 cycles (two automated mixes per cycle) and in a stringent buffer (100 mM morpholinoethanesulfonic
                        acid, 0.1 M NaCl, and 0.01% Tween-20) for four cycles (15 automated mixes per cycle), and stained with streptoavidin-conjugated
                        phycoerythrin to identify hybridized biotin–labeled cRNA. This procedure was followed by an incubation with biotinylated mouse
                        anti-avidin antibody and restaining with streptoavidin-conjugated phycoerythrin to amplify the signal for hybridized biotin-labeled
                        cRNA. The chips were scanned in a HP ChipScanner (Affymetrix Inc, Santa Clara, CA) to detect hybridization signals. Hybridization
                        data were normalized to an average target intensity of 500 per chip, and then analysis of induced versus uninduced PITT1 cells
                        at baseline was performed with the program GCOS version 1.0.
                     </p>
                     <p id="p-32">A PubMed search was conducted to identify articles containing Affymetrix datasets on human leiomyosarcoma or prostate cancer
                        by use of the following search terms: “Affymetrix,” “primary prostate cancer,” and “primary leiomyosarcoma.” Seven relevant
                        articles about prostate cancer and one for human soft tissue leiomyosarcoma were found. Four sets of data from these eight
                        articles were selected because of their availability. Among them, three were from University of Pittsburgh and one was from
                        Memorial Sloan-Kettering Cancer Institute. For meta-analysis, Affymetrix CEL files of all samples from the four articles (<a id="xref-ref-15-2" class="xref-bibr" href="#ref-15">15–17</a>,<a id="xref-ref-19-2" class="xref-bibr" href="#ref-19">19</a>) were reanalyzed with GCOS version 1.0 and normalized to an average target intensity of 500 for each sample. The results
                        were exported to Microsoft Excel for statistical analysis. Fold changes of integrin α7 in tumor samples were calculated as
                        average intensity of tumor samples over average of the normal controls in the same set of data. Two-sided Student's <em>t</em> tests were performed to obtain <em>P</em> values. Confidence intervals (CIs) were calculated as described below. The number of samples analyzed from each article was
                        as follows: 156 samples from Yu et al. (<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">17</a>), 30 from Luo et al. (<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>), 26 from LaTulippe et al. (<a id="xref-ref-15-3" class="xref-bibr" href="#ref-15">15</a>), and 29 from Ren et al. (<a id="xref-ref-19-3" class="xref-bibr" href="#ref-19">19</a>).
                     </p>
                  </div>
                  <div id="sec-25" class="subsection">
                     <h3>Statistical Methods</h3>
                     <p id="p-33">Confidence intervals for individual proportions were calculated by use of the exact binomial test (function “binom.test” in
                        R package of statistical computer programs), and those for a numerical distribution were calculated with conventional independent
                        and normal assumption (i.e., mean ± [1.96 × SD/n<sup>1/2</sup>], where SD = standard deviation and n = sample size) (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>). Comparison of two proportions was inferred by Fisher's exact test because of relatively small sample size (function “fisher.test”
                        in R package) (<a id="xref-ref-18-3" class="xref-bibr" href="#ref-18">18</a>). The odds ratio (OR) estimates and the confidence intervals were inferred by conditional maximum likelihood estimate rather
                        than conventional sample odds ratio. Survival was analyzed by the Kaplan–Meier method, and survival curves were compared by
                        use of the log-rank test (<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">22</a>). All statistical tests were two-sided.
                     </p>
                  </div>
               </div>
               <div class="section" id="sec-26">
                  <div class="section-nav"><a href="#sec-11" title="Patients, Materials, and Methods"
                        class="prev-section-link"><span>Previous Section</span></a><a href="#sec-28" title="Discussion" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Results</h2>
                  <div id="sec-27" class="subsection">
                     <h3>Mutations of Integrin α7 in Human Malignancies</h3>
                     <p id="p-34">To investigate whether qualitative alterations in the integrin α7 gene occur in human cancers, we sequenced integrin α7 genomic
                        DNA and cDNA from 66 human cancer specimens (including 28 prostate cancers, 24 hepatocellular carcinomas, six glioblastoma
                        multiformes, and four leiomyosarcomas specimens) and cancer cell lines (including PC3, Du145, and LNCaP cells derived from
                        prostate cancers and SK-UT-1 cells derived from a leiomyosarcoma). In addition, integrin α7 genomic DNA and cDNA from 56 specimens
                        from matched nontumor tissues were sequenced. Two types of alterations in the integrin α7 sequence were associated with human
                        malignancies: changes in the amino acid sequence caused by missense mutations and protein truncations caused by nonsense,
                        deletion, or insertion mutations (Supplementary Fig. 2, A and B; available online).
                     </p>
                     <p id="p-35">Integrin α7 contains only 50 amino acid residues in its carboxyl-terminal cytoplasmic domain; truncations in this domain should
                        adversely affect in its signal transduction ability and other functions. Because truncation mutations have the strongest impact
                        on the structure of the protein, we focused our analysis on such mutations. Truncation mutations of integrin α7 occurred at
                        high frequency in samples from human malignancies (<a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a>). In the prostate cancer specimens, the rate of integrin α7 mutations was 57% (95% CI = 37% to 76%; i.e., 16 mutations in
                        28 specimens). In glioblastoma multiforme specimens, the rate reached 83% (95% CI = 36% to 99%; i.e., five mutations in six
                        specimens); in leiomyosarcoma specimens, the rate was 25% (95% CI = 0.6% to 81%; i.e., one mutation in four specimens); and
                        in hepatocellular carcinoma specimens, the rate was 21% (95% CI = 7% to 42%; i.e., five in 24 specimens). All of these mutations
                        had major structural consequences (Supplementary Fig. 2, A; available online), including protein truncation because of a premature
                        stop codon, a frameshift because of deletions or insertions of nucleotides, or loss of the translational start site.
                     </p>
                     <div class="table pos-float" id="T1">
                        <div class="table-inline">
                           <div class="callout"><span>View this table:</span><ul class="callout-links">
                                 <li><a href="868/T1.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="868/T1.expansion.html">In a new window</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="table-caption"><span class="table-label">Table 1</span> 
                           <p id="p-36" class="first-child">Mutation frequency of integrin α7 in primary malignancies*</p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <p id="p-39">The integrin α7 mutations were spread across the coding region, but a hot spot (n = 9 specimens) was identified in codon 921,
                        in which a glutamine codon was mutated to a stop codon. Fourteen samples contained both truncation and missense mutations,
                        10 of which were identified as mutations in separate alleles. Prostate cancers with integrin α7 mutations, compared with those
                        without such a mutation, were generally less differentiated (Fisher's exact test, <em>P</em> = .009), had a more advanced stage (<em>P</em> = .005), and were more likely to be associated with relapse (nine recurrences among 13 patients with integrin α7 mutations
                        versus one among eight without such mutations; odds ratio = 14, 95% CI = 1.15 to 782, <em>P</em> = .024). However, the only association for hepatocellular carcinomas with integrin α7 mutations was with shorter relapse-free
                        survival than tumors without such mutations (five recurrences among eight patients with integrin α7 mutations versus one among
                        16 without such mutations, OR = 21, 95% CI = 1.6 to 1245; <em>P</em> = .007) (<a id="xref-table-wrap-2-1" class="xref-table" href="#T2">Table 2</a>).
                     </p>
                     <div class="table pos-float" id="T2">
                        <div class="table-inline">
                           <div class="callout"><span>View this table:</span><ul class="callout-links">
                                 <li><a href="868/T2.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="868/T2.expansion.html">In a new window</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="table-caption"><span class="table-label">Table 2</span> 
                           <p id="p-40" class="first-child">Pathologic and clinical factors and integrin α7 mutations*</p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <p id="p-47">PC-3 cells contain a frameshift mutation at codon 759 in one integrin α7 allele, and Du145 cells contain a two–amino acid
                        deletion mutation in integrin α7. SK-UT-1 cells have a premature stop codon at position 350 in one integrin α7 allele, so
                        that integrin α7 protein is expressed only from the remaining nonmutated allele. Cell lines H1299 and H358 express normal
                        wild-type levels of integrin α7 and lack integrin α7 mutations. To examine the effect of alterations in the level of integrin
                        α7 mutations on tumorigenesis (as assessed by colony formation and growth in soft agar), we increased the level of integrin
                        α7 in the deficient cell lines (i.e., PC3, Du145, and SK-UT-1) to normal wild-type levels by use of an integrin α7 expression
                        vector (pCMV-integrin α7 vector) or decreased its level by 70% by use of siRNA against integrin α7. For the cells with deficient
                        levels of integrin α7, we selected PC-3 and Du145 cells, which were derived from human metastatic prostate cancers, and SK-UT-1
                        cells, which were derived from a human leiomyosarcoma (Supplementary Fig. 2, A; available online). For cell lines with normal
                        levels of integrin α7 expression, we selected H1299 and H358 cells, which were derived from human lung cancers. We first increased
                        integrin α7 expression to normal wild-type levels in PC-3, Du145, and SK-UT-1 cells by transfecting them with an integrin
                        α7 expression vector (pCMV-integrin α7 vector) and then compared the ability of these cells to form colonies and grow on soft
                        agar with that of corresponding pCMVscript-transfected control cells (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Fig. 1, A</a>). In the colony formation assay, the rate of colony formation was reduced by 7.1-fold (95% CI = 4.91-fold to 9.38-fold) in
                        integrin α7–transfected PC-3 cells as compared with pCMVscript-transfected control PC-3 colonies, by 6-fold (95% CI = 3.87-fold
                        to 8.13-fold) in integrin α7–transfected Du145 cells as compared with pCMVscript-transfected control Du145 colonies, and by
                        5.9-fold (95% CI = 5.59-fold to 6.28-fold) in integrin α7–transfected SK-UT-1 cells as compared with pCMVscript-transfected
                        control SK-UT-1 colonies. In the soft agar growth assay, pCMVscript-transfected control cells formed large colonies with up
                        to 100 cells on soft agar, but integrin α7–transfected cells with higher (normal) levels of integrin α7 expression formed
                        fewer and smaller colonies (<a id="xref-fig-1-2" class="xref-fig" href="#F1">Fig. 1, B</a>). Specifically, for PC-3 cells, there was a 3.8-fold (95% CI = 3.15-fold to 4.39-fold) reduction in colony formation; for
                        Du145 cells, there was a 3.2-fold (95% CI = 2.83-fold to 3.62-fold) reduction; and for SK-UT-1 cells, there was a 2.6-fold
                        (95% CI = 2.25-fold to 2.80-fold) reduction. In a second set of experiments, we decreased the level of integrin α7 in H1299
                        and H358 cells by transfecting cells with integrin α7–specific siRNAs or scrambled siRNAs expressing vectors and then investigated
                        the colony formation ability and growth on soft agar of these cells. Both integrin α7–specific siRNA-expressing cell lines
                        formed more colonies and grew better on soft agar than their corresponding scramble control cell lines (<a id="xref-fig-1-3" class="xref-fig" href="#F1">Fig. 1</a>).
                     </p>
                     <div id="F1" class="fig pos-float odd">
                        <div class="fig-inline"><a href="868/F1.expansion.html"><img alt="Fig. 1" src="868/F1.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="868/F1.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="868/F1.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/99/11/868/F1">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Fig. 1</span> 
                           <p id="p-48" class="first-child">Tumor suppressor activity of integrin α7 in vitro and in vivo. For cells with low integrin α7 expression, assays were performed
                              with cells transfected with pCMVscript (control) or with pCMV-ITGA7 (an integrin α7 expression construct). Control-transfected
                              PC-3 cells were P4 and P5 cells, and integrin α7 expression construct–transfected PC-3 cells were IT4 and IT8 cells. Control-transfected
                              Du145 cells were DP1 and DP2 cells, and integrin α7 expression construct–transfected Du145 cells were ITDu3 and ITDu4 cells.
                              Control-transfected SK-UT-1 cells were PSK1 and PSK3 cells, and integrin α7 expression construct-transfected SK-UT-1 cells
                              were ISK3 and ISK7 cells. For H1299 and H358 cells, which have normal levels of integrin α7 expression, cells were transfected
                              with small interfering RNAs (siRNAs) integrin α7 (to inhibit integrin α7 expression) or an RNA with an siRNA with a scrambled
                              sequence as the control. <strong>A</strong>) Colony formation analysis of integrin α7–transfected cells (10 days). Immunoblots of these clones with antibodies against
                              integrin α7 and β-actin and representative images of hematoxylin staining of colonies are shown in Supplementary Fig. 3 (available
                              online). Data are the mean and 95% confidence intervals (CIs). <strong>B</strong>) Soft agar anchorage–independent growth analysis of integrin α7–transfected cells (22 days). Cells were assayed for their
                              ability to grow in soft agar. Data are the means and 95% confidence intervals. Representative images of colonies formed in
                              0.4% soft agar 22 days after inoculation are shown in Supplementary Fig. 3 (available online). <strong>C</strong>) Wound-healing analysis of integrin α7–transfected cells. Cells were assayed for their ability to recover from similarly
                              sized artificial scratches. Data are the mean percentage of area recovered and their 95% confidence interval. <strong>D</strong>) Reduction of tumor volume of integrin α7–expressing tumor cells in severe combined immune deficient (SCID) mice. Clones
                              of integrin α7–expressing PC-3 and Du145 cells and their corresponding controls were assayed for tumor growth in SCID mice
                              within 6 weeks of tumor cell inoculation. The number of mice in each group and its 95% confidence interval are indicated.
                              <strong>E</strong>) Suppression of metastasis in integrin α7–expressing tumor cells. Incidences of metastases from two clones of each cell lineage
                              were tabulated at the end of 6 weeks or at the time of premature deaths. The rate of metastasis for P4, P5, or DP1 cells was
                              2/6 or 33% (95% CI = 4% to 78%), and for DP2 cells, it was 1/6 or 17% (95% CI = 0.4% to 64%). The rate of metastasis for P4
                              and P5 cells combined was 33% (95% CI = 10% to 65%); for IT4 and IT cells, it was 0%; for DP1 and DP2 cells, it was 25% (95%
                              CI = 5% to 57%); and for ITDU3 and ITDU4 cells, it was 0%. The number of mice in each group that died before 42 days was as
                              follows: for P4 tumors, three of the six mice died; for P5 cells, four of the six; for IT4 cells, one of the six; for IT8
                              cells, zero of the six; for DP1 cells, four of the six; for DP2 cells, five of the six; for ITDU3 cells, one of the six; for
                              ITDU4 cells, one of the six. <strong>F</strong>) Survival analysis. Kaplan–Meier survival analyses of SCID mice bearing the following xenograft tumors: IT4 and IT8 (integrin
                              α7–transfected) and P4 and P5 (control-transfected) derived from PC-3 cells (left) and ITDu3 and ITDu4 (integrin α7–transfected)
                              and DP1 and DP2 (control-transfected) derived from Du145 cells (right). <em>P</em> values were from log-rank tests. In PC-3 cells at risk at 37 days, six (95% CI = 3 to 9) mice in the control-transfected
                              group and 12 (95% CI = 9 to 12) mice in the integrin α7–transfected group were at risk. At 42 days, five (95% CI = 2 to 9)
                              mice were at risk in the control-transfected group and 11 (95% CI = 7 to 12) mice were at risk in the integrin α7–transfected
                              group. For Du145 cells (right) at 37 days, six (95% CI = 3 to 9) mice in the control-transfected group and 12 (95% CI = 9
                              to 12) mice in the integrin α7–transfected group were at risk. At 42 days, three (95% CI = 1 to 7) mice in the control-transfected
                              group and 10 (95% CI = 6 to 12) mice in the integrin α7–transfected group were at risk. All statistical tests were two-sided.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <p id="p-49">To investigate the role of integrin α7 in metastasis, we examined the relationship between the level of integrin α7 expression
                        and cell migration by use of wound-healing assays with PC-3, Du145, SK-UT-1, H1299, and H358 cells. When the expression of
                        integrin α7 was increased in PC-3, Du145, and SK-UT-1 cells with low integrin α7 expression by transfecting cells with integrin
                        α7 expression vectors, the rate of migration, compared with that in corresponding pCMVscript-transfected cells, was reduced
                        by 5.4-fold (95% CI = 4.68-fold to 6.19-fold), 4.3-fold (95% CI = 3.86-fold to 4.64-fold), and 11.7-fold (95% CI = 5.59-fold
                        to 17.85-fold), respectively (<a id="xref-fig-1-4" class="xref-fig" href="#F1">Fig. 1, C</a>). When integrin α7 expression in H1299 and H358 cells, which express a normal level of integrin α7 and have low motility,
                        was decreased by transfection with an integrin α7–specific siRNA increased the rate of migration by 2-fold (95% CI = 1.57-fold
                        to 2.41-fold) compared with that of corresponding scrambled siRNA-transfected control cells. Thus, the level of integrin α7
                        expression appears to be inversely associated with tumor cell migration.
                     </p>
                     <p id="p-50">To investigate the tumor suppressor activity of integrin α7, we generated xenograft tumors in SCID mice implanted with vector-transfected
                        PC-3 and Du145 prostate cancer cells and corresponding cells transfected with integrin α7 expression constructs and then compared
                        the volume of tumors as a function of integrin α7 expression. Six weeks after implantation, tumors from integrin α7–transfected
                        Du145 cells had an average volume of 0.8 cm<sup>3</sup>, and tumors from vector-transfected Du145 cells had an average volume of 2.2 cm<sup>3</sup> (difference = 1.4 cm<sup>3</sup>, 95% CI of difference = 0.9 to 2.1, <em>P</em> = .001) (<a id="xref-fig-1-5" class="xref-fig" href="#F1">Fig. 1, D</a>). Similarly, 6 weeks after implantation, the volume of tumors from integrin α7–transfected PC-3 cells was 0.7 cm<sup>3</sup> and that from vector-transfected PC-3 cells was 2.9 cm<sup>3</sup> (difference = 2.2, 95% CI of difference = 1.5 to 2.9, <em>P</em>&lt;.001) (<a id="xref-fig-1-6" class="xref-fig" href="#F1">Fig. 1, D</a>). No visible metastases were identified in mice with integrin α7–transfected Du145 or PC-3 tumors. However, metastasis was
                        observed in three (25%) of the 12 mice with vector-transfected Du145 tumors and in four (33%) of the 12 mice with vector-transfected
                        PC-3 tumors (<a id="xref-fig-1-7" class="xref-fig" href="#F1">Fig. 1, E</a>). Furthermore, the 6-week survival of mice bearing integrin α7–transfected Du145 tumors (83%, 95% CI = 62% to 100%) or PC-3
                        tumors (92%, 95% CI = 76% to 100%) was higher than that of mice bearing tumors from the corresponding vector-transfected cells
                        tumors (25%, 95% CI = 0.5% to 49.5%, and 42%, 95% CI = 13.8% to 69.5%) (<a id="xref-fig-1-8" class="xref-fig" href="#F1">Fig. 1, F</a>). Thus, increased integrin α7 was associated with decreased tumor growth and metastasis in vivo.
                     </p>
                     <p id="p-51">To determine whether the expression of integrin α7 alters the global gene expression profile, we transfected PC-3 and SK-UT-1
                        cells with a tetracycline-inducible integrin α7 expression vector (pCDNA4-ITGA7) and used microarray analysis to compare gene
                        expression in these cells in the presence of tetracycline with that in uninduced cells. Within 24 hours of integrin α7 induction,
                        we found a 6.1-fold (95% CI = 5.5-fold to 6.8-fold) increase in the expression of CDKN3 mRNA in induced PC-3 cells transfected
                        with pCDNA4-ITGA7 compared with uninduced cells (that is, 8593 arbitrary units in induced cells and 1408 arbitrary units in
                        uninduced cells) and a 5.8-fold (95% CI = 5.23-fold to 6.41-fold) increase in the expression of CDKN3 protein (with CDKN3/β-actin
                        ratio increasing from 0.043 in noninduced cells to 0.249 in induced cells) (<a id="xref-fig-2-1" class="xref-fig" href="#F2">Fig. 2, A</a>). We found a 5-fold (95% CI = 4.26-fold to 5.70-fold) increase in CDKN3 protein expression in SK-UT-1 cells transfected with
                        integrin α7 compared with the same cells transfected with vector control (with the CDKN3/β-actin ratio increasing from 0.042
                        in uninduced cells to 0.214 in induced cells). Within 24 hours of integrin α7 induction, we also found a 3-fold (95% CI =
                        3.35-fold to 3.65-fold) increase of RACGAP1 mRNA in induced PC-3 cells transfected with pCDNA4-ITGA7 compared with uninduced
                        cells (from 715 units in uninduced cells to 2146 units in induced cells). Within 24 hours of integrin α7 induction, RACGAP1
                        protein expression was increased 2.8-fold (95% CI = 2.60-fold to 3.00-fold) in pCDNA4-ITGA7–transfected PC-3 cells, compared
                        with uninduced cells (with RACGAP1/β-actin ratio increasing from 0.049 in uninduced cells to 0.139 in induced cells), and
                        3.3-fold (95% CI = 2.73-fold to 3.86-fold) in SK-UT-1 cells (with RACGAP1/β-actin ratio increasing from 0.044 in uninduced
                        cells to 0.148 in induced cells). Thus, integrin α7 expression may lead to the activation of several genes, including CDKN3
                        and RACGAP1.
                     </p>
                     <div id="F2" class="fig pos-float odd">
                        <div class="fig-inline"><a href="868/F2.expansion.html"><img alt="Fig. 2" src="868/F2.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="868/F2.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="868/F2.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/99/11/868/F2">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Fig. 2</span> 
                           <p id="p-52" class="first-child">Integrin α7 and the expression of cyclin D kinase inhibitor 3 (CDKN3) and the GTPase-activating protein RACGAP1. <strong>A</strong>) Immunoblot analysis of integrin α7, CDKN3, RACGAP1, and β-actin expression. Lysates of pcDNA4-ITGA7–transfected PC-3 cells
                              (PITT1 and PITT2 clones) with (I) or without (U) tetracycline treatment to induce the expression of integrin α7 and lysates
                              of pCMV-ITGA7-transfected SK-UT-1 cells (ISK3 and ISK7 cells), which constitutively express integrin α7, and their corresponding
                              vector controls (PSK1 and PSK3 cells) were electrophoresed, and proteins were transferred to a membrane and probed with antibodies
                              specific for integrin α7 (ITGA7, rabbit polyclonal), CDKN3 (mouse monoclonal), RACGAP1 (goat polyclonal), and β-actin (as
                              the loading control). <strong>B–D</strong>) Cells were treated with (+) or without (–) tetracycline (to induce integrin α7) and/or transfected with RACGAP1 small interfering
                              RNA (siRNA), CDKN3 siRNA, and/or scrambled siRNA (control), as shown in the bottom of panel <strong>D</strong>. Data are the means of triplicates; <strong>error bars</strong> are 95% confidence intervals. <strong>B</strong>) CDKN3 and RACGAP1 expression and RNA interference. The expression of CDKN3 and RACGAP1 were analyzed by immunoblotting with
                              corresponding antibodies. β-Actin, detected with antibodies against β-actin, was used as the loading control. <strong>C</strong>) Soft agar colony formation assay. Data are the mean of number of colonies formed after 22 days; <strong>error bars</strong> are 95% confidence intervals. <strong>D</strong>) Cell migration. Data are the mean of the percentage of the area recovered after migration for 24 hours (n = 5 areas); <strong>error bars</strong> are 95% confidence intervals.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <p id="p-53">To evaluate the importance of CDKN3 and RACGAP1 in integrin α7–mediated tumor suppressor and motility inhibition activities,
                        we used RNA interference for CDKN3 and RACGAP1, PC-3 cells that were transfected with a tetracycline-inducible integrin α7
                        expression vector (pCDNA4-ITGA7), and SK-UT-1 cells that were transfected with pCMV-ITGA7 or pCMVscript. We evaluated tumor
                        suppressor activity with the colony formation assay and motility with a wound-healing assay. Inhibition of CDKN3 expression
                        by 80% in PC3 cells transfected with pCDNA4-ITGA7 and induced with tetracycline reduced integrin α7–mediated soft agar colony
                        growth inhibition by 85% (95% CI = 83.9% to 87.6%), and inhibition of RACGAP1 reduced it by 32% (95% CI = 26.4% to 37.5%)
                        (<a id="xref-fig-2-2" class="xref-fig" href="#F2">Fig. 2, B</a>–D). When the expression of both CDKN3 and RACGAP1 was inhibited with corresponding siRNAs, integrin α7 tumor suppressor activity
                        was virtually abolished (i.e., reduced by 99%, 95% CI = 99% to 100%). Thus, the combination of CDKN3 and RACGAP1 may mediate
                        integrin α7 tumor suppression, although CDKN3 appears to be the dominant target. Similar results were also found with the
                        leiomyosarcoma cell line SK-UT-1. In contrast, inhibition of RACGAP1 with a RACGAP1 siRNA reversed the inhibition of motility
                        by integrin α7 by 70%, whereas CDKN3 alone was virtually ineffective in motility inhibition (5%) (<a id="xref-fig-2-3" class="xref-fig" href="#F2">Fig. 2, D</a>). The combination of CDKN3 and RACGAP1 siRNAs in PITT1 and PITT2 cells did not result in additional reversal of inhibition
                        of motility, indicating that RACGAP1 is the main target for motility inhibition induced by integrin α7.
                     </p>
                     <p id="p-54">Meta-analysis of microarray data on integrin α7 expression found low integrin α7 expression (2.7-fold decreased to 4.5-fold
                        decreased expression) in human prostate cancer specimens from Memorial Sloan-Kettering Cancer Institute and University of
                        Pittsburgh that did not metastasize but even lower expression (4.4-fold decreased to 6.1-fold decreased expression) in those
                        that metastasized, when compared with normal prostate (4325 units on average) (<a id="xref-ref-15-4" class="xref-bibr" href="#ref-15">15</a>–<a id="xref-ref-17-2" class="xref-bibr" href="#ref-17">17</a>) (<a id="xref-table-wrap-3-1" class="xref-table" href="#T3">Table 3</a>). Soft tissue leiomyosarcomas that did not metastasize and normal smooth muscle tissue had approximately the same level of
                        integrin α7 expression, but integrin α7 expression in highly aggressive soft tissue leiomyosarcomas was decreased by 41.1-fold
                        (95% CI = 37.4-fold to 44.8-fold), compared with normal smooth muscle (<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">23</a>). RT–PCR analyses of 20 human organs and 16 cell lines derived from tumors of prostate, brain, liver, smooth muscle, lung,
                        and kidney detected expression of integrin α7 mRNAs in all tissues and cell lines examined (data not shown).
                     </p>
                     <div class="table pos-float" id="T3">
                        <div class="table-inline">
                           <div class="callout"><span>View this table:</span><ul class="callout-links">
                                 <li><a href="868/T3.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="868/T3.expansion.html">In a new window</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="table-caption"><span class="table-label">Table 3</span> 
                           <p id="p-55" class="first-child">Meta-analysis of integrin α7 expression in cancer tissues*</p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <p id="p-57">We used immunostaining of tissues to determine whether integrin α7 protein expression was decreased in prostate cancer and
                        leiomyosarcoma, compared with normal tissues. Immunostaining of prostate tissues with rabbit anti–integrin α7 antiserum showed
                        that normal prostate gland tissue had a moderate level of integrin α7 expression, with an average score of 1.82 (95% CI =
                        1.74 to 1.89). The acinar cells were more intensely stained than the basal cells. In contrast, many prostate cancer tissues
                        had no integrin α7 or only focal positive staining for integrin α7, with an average score of 0.740 (95% CI = 0.699 to 0.789,
                        <em>P</em>&lt;.001) (<a id="xref-fig-3-1" class="xref-fig" href="#F3">Fig. 3, A</a>, and <a id="xref-table-wrap-4-1" class="xref-table" href="#T4">Table 4</a>). A further decrease in the level of integrin α7 expression was observed in metastasizing prostate cancer tumors, with an
                        average score of 0.414 (95% CI = 0.348 to 0.480) (<a id="xref-table-wrap-4-2" class="xref-table" href="#T4">Table 4</a>). Strong integrin α7 expression was identified in smooth muscle tissue surrounding small vessels. Soft tissue leiomyosarcoma
                        tissue from patients with a relatively mild clinical course (i.e., tumor-free survival of patients was &gt;5 years) had slightly
                        lower integrin α7 expression (average score = 1.125, 95% CI = 0.876 to 1.373) than normal smooth muscle (1.43, 95% CI = 1.239
                        to 1.614), and aggressive soft tissue leiomyosarcoma tissue (from patients with a relapse within 5 years) had much lower integrin
                        α7 expression (0.625, 95% CI = 0.456 to 0.794) (<a id="xref-table-wrap-4-3" class="xref-table" href="#T4">Table 4</a>). Among patients contributing prostate cancer or leiomyosarcoma samples (<a id="xref-fig-3-2" class="xref-fig" href="#F3">Fig. 3, B</a>), statistically significant decreases in 5-year metastasis-free survival were associated with little or no expression of
                        integrin α7 in tumors, compared with at least weak expression of integrin α7 in tumors (for example, among patients with prostate
                        cancer, 5-year metastasis-free survival rate associated with tumors with focal or no integrin α7 expression was 32%, 95% CI
                        = 24.4% to 40.3%, and that associated with higher integrin α7 expression was 85%, 95% CI = 79.0% to 91.0%; <em>P</em>&lt;.001). These results support a role of integrin α7 in cancer metastasis and indicate that integrin α7 may have a role in
                        cancer behavior.
                     </p>
                     <div id="F3" class="fig pos-float odd">
                        <div class="fig-inline"><a href="868/F3.expansion.html"><img alt="Fig. 3" src="868/F3.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="868/F3.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="868/F3.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/99/11/868/F3">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Fig. 3</span> 
                           <p id="p-58" class="first-child">Integrin α7 expression and relapse-free survival in patients with prostate cancer or leiomyosarcoma. <strong>A</strong>) Integrin α7 immunostaining in normal prostate tissues, prostate cancer, normal smooth muscle of small arteriole and vein,
                              and soft tissue leiomyosarcoma. Immunohistochemistry was performed with purified integrin α7 peptide antiserum (1:1000 dilution).
                              The sections were incubated with horseradish peroxidase–conjugated anti-rabbit IgG for 30 minutes at room temperature and
                              then with 3,3′-diaminobenzidine solution. <strong>B</strong>) Relapse-free survival of patients with prostate cancer (left) or with leiomyosarcoma (right) stratified by integrin α7 expression.
                              The cut point used was an integrin α7 score of 0.5 or less versus more than 0.5. Analysis includes only samples with more
                              than 60 months clinical follow-up. <em>P</em> values were from log-rank tests. In prostate cancer, 66 (95% confidence interval [CI] = 54 to 78) patients were at risk at
                              30 months in the ITGA7 group with a score of 0.5 or less and 120 (95% CI = 112 to 126) patients were at risk at 30 months
                              in the ITGA7 group with a score of more than 0.5. At the 60-month time point, 42 (95% CI = 32 to 53) patients were at risk
                              in the ITGA7 group with a score of 0.5 or less and 113 (95% CI = 103 to 120) patients were at risk in the ITGA7 group with
                              a score of more than 0.5 group. In leiomyosarcoma, 11 (95% CI = 6 to 17) patients were at risk at 30 months in the ITGA7 group
                              with a score of 0.5 or less and 23 (95% CI = 17 to 27) patients were at risk at 30 months in the ITGA7 group with a score
                              of more than 0.5. At the 60-month time point, four (95% CI = 1 to 9) patients were at risk in the ITGA7 group with a score
                              of 0.5 or less and 16 (95% CI = 10 to 22) patients were at risk in the ITGA group with a score of more than 0.5. All statistical
                              tests were two-sided.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <div class="table pos-float" id="T4">
                        <div class="table-inline">
                           <div class="callout"><span>View this table:</span><ul class="callout-links">
                                 <li><a href="868/T4.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="868/T4.expansion.html">In a new window</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="table-caption"><span class="table-label">Table 4</span> 
                           <p id="p-59" class="first-child">Immunostaining of integrin α7 in human prostate cancer and leiomyosarcoma samples</p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                  </div>
               </div>
               <div class="section" id="sec-28">
                  <div class="section-nav"><a href="#sec-26" title="Results" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="Footnotes" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Discussion</h2>
                  <p id="p-61">We report, to our knowledge for the first time, that mutations in the integrin α7 gene appear to be widespread and frequent
                     in human malignancies. We also found by use of RT–PCR that integrin α7 mRNA was readily detected in tissues of 20 normal organs
                     (data not shown). Moreover, we detected integrin α7 mRNA in all 16 cell lines examined that were derived from tumors of prostate
                     gland, lung, brain, smooth muscle, liver, and kidney (data not shown). The presence of mutations in cDNA and genomic DNA from
                     tumor samples and the absence of similar mutations in the matched normal samples largely eliminated the possibility of pseudogene
                     mutations because pseudogene should be present in both normal and tumor samples. Thus, the ubiquitous expression of integrin
                     α7 in human organs and widespread mutations of this gene in human cancers raise the possibility that integrin α7 may have
                     a role in the development of many human malignancies.
                  </p>
                  <p id="p-62">To our knowledge, this is also the first report that integrin α7 appears to function as a tumor suppressor in human malignancies.
                     Several lines of evidences support a tumor suppressor role of integrin α7 in mammalian cells. First, in three different tumor
                     cell culture systems, a normal level of integrin α7 expression suppressed tumor growth, and lower levels of integrin α7 expression
                     promoted tumor growth. In addition, mice bearing xenograft tumors from either of two highly aggressive prostate cancer cell
                     lines had reduced tumor volume, fewer metastases, and fewer deaths if the expression of integrin α7 in the cells from which
                     the tumors were derived was increased by transfection with integrin α7 constructs, compared with those in mice bearing xenografts
                     from cell lines transfected with control vector. Second, decreased integrin α7 expression was detected in human prostate tumor
                     tissue samples and in highly aggressive soft tissue leiomyosarcoma samples by two comprehensive protein expression analyses
                     that used data from immunostaining assays. These findings were further supported by findings from several independent microarray
                     datasets in which prostate cancer and soft tissue leiomyosarcoma specimens expressed lower levels of integrin α7 mRNA than
                     corresponding normal tissue specimens. Third, integrin α7 expression appeared to activate the expression of CDKN3 and RACGAP1.
                     CDKN3 has been shown to dephosphorylate tyrosine residues of several CDKs (including CDK2, CDK3, and CDC2) and inhibit cell
                     cycle progression in yeast and mammalian cells (<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">24</a>,<a id="xref-ref-25-2" class="xref-bibr" href="#ref-25">25</a>). RACGAP1 has been shown to suppress growth and induce differentiation in hematopoietic cells (<a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">26</a>). Thus, by activating CDKN3 and RACGAP1, integrin α7 appears to prevent cell cycle progression and suppress tumor growth.
                     Consistent with these findings, the expression of integrin α7 was strongest in the terminally differentiated prostate acinar
                     cells of the prostate gland but was weakest in basal or stem cell layers of both organs, indicating that integrin α7 may prevent
                     the overgrowth of highly differentiated tissues. This cell growth inhibitory activity of integrin α7 may be mediated by activating
                     the expression of CDKN3 and RACGAP1. Our analyses also indicated that integrin α7 inhibits cell motility and reduces metastases.
                     Inhibition of both growth and motility may mean that integrin α7 is in a position to counteract proliferation and invasion
                     of malignant cells.
                  </p>
                  <p id="p-63">Our study has several limitations. Limitations involving the interpretation of data from cells with forced expression of integrin
                     α7 include the artificial cultural system, variations in clonal selection, and the lack of an antitumor immune system in the
                     mice used in our experiments. However, when integrin α7 expression in nonmutant cell lines was reduced by use of siRNA against
                     integrin α7, the tumorigenicity of these cell lines increased, which is consistent with our hypothesis that removal of integrin
                     α7 enhances tumorigenesis. Another limitation is that the signaling pathway used by integrin α7 to activate the transcription
                     of CDKN3 and RACGAP1 mRNAs has not been identified. Micorarray analysis indicates that PC-3 cells express other integrin α
                     and β types in addition to integrin α7 and integrin β1 (data not shown), but induction of integrin α7 expression did not appear
                     to alter the expression of other integrin molecules. Consequently, to form a heterodimer with β1 subunit, integrin α7 may
                     have to displace mutated integrin α7 (or another integrin α) subunit from the complex, which could alter the homeostasis of
                     integrin signaling and thus alter cell growth.
                  </p>
                  <p id="p-64">The function of integrin α7 in prostate gland and smooth muscle appears to be related to the adhesion of cells to the basement
                     membrane and prevention of the random migration of these cells to other organs. Another important function of integrin α7
                     appears to be its role in limiting cell proliferation because expression of integrin α7 induced the expression of proteins
                     that inhibit cell cycle progression and cell growth. When the level of integrin α7 protein was decreased or the protein was
                     mutated, cells appeared to lose inhibitory signals for both cell migration and proliferation. This loss may lead to unchecked
                     tumor cell proliferation and a higher incidence of metastases. Thus, impairing the function of integrin α7 may be an efficient
                     mechanism of carcinogenesis.
                  </p>
               </div>
               <div class="section fn-group" id="fn-group-1">
                  <div class="section-nav"><a href="#sec-28" title="Discussion" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Footnotes</h2>
                  <ul>
                     <li class="fn" id="fn-11">
                        <p id="p-65">This work was supported by grants from National Cancer Institute to G. K. Michalopoulos (1UO1CA88110-01), to C. Wu (RO1 GM65188),
                           and to J.-H. Luo (RO1 CA098249); the development fund from Department of Urology; and the John Rangos Foundation for Enhancement
                           of Research in Pathology.
                        </p>
                     </li>
                     <li class="fn" id="fn-12">
                        <p id="p-66">The authors had full responsibility for the design of the study, the collection of the data, the analysis and interpretation
                           of the data, the decision to submit the manuscript for publication, and the writing of the manuscript.
                        </p>
                     </li>
                     <li class="fn" id="fn-13">
                        <p id="p-67">Funding to pay the Open Access publication charges for this article was provided by a grant (R01 CA098249) from the National
                           Cancer Institute.
                        </p>
                     </li>
                  </ul>
               </div>
               <ul>
                  <li class="fn" id="copyright-statement-1">© 2007 The Author(s).</li>
               </ul>
               <div class="license">
                  <p id="p-1">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/),
                     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is
                     properly cited.
                  </p>
               </div>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#fn-group-1" title="Footnotes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label">(1)</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference (1) in text"
                           id="ref-1">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.1"
                             data-doi="10.1016/S0092-8674(02)00971-6">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hynes</span>  <span class="cit-name-given-names">RO</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Integrins: bidirectional, allosteric signaling machines</span>. <abbr class="cit-jnl-abbrev">Cell</abbr> <span class="cit-pub-date">2002</span>;<span class="cit-vol">110</span>:<span class="cit-fpage">673</span>-<span class="cit-lpage">87</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0092-8674(02)00971-6&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12297042&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000178182800004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Integrins%3A%20bidirectional%2C%20allosteric%20signaling%20machines&amp;author=RO%20Hynes&amp;publication_year=2002&amp;journal=Cell&amp;volume=110&amp;pages=673-87">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(2)</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference (2) in text"
                           id="ref-2">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.2"
                             data-doi="10.1016/S0945-053X(98)00005-5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pulkkinen</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Uitto</span>  <span class="cit-name-given-names">J</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Mutation analysis and molecular genetics of epidermolysis bullosa</span>. <abbr class="cit-jnl-abbrev">Matrix Biol</abbr> <span class="cit-pub-date">1999</span>;<span class="cit-vol">18</span>:<span class="cit-fpage">29</span>-<span class="cit-lpage">42</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0945-053X(98)00005-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10367729&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000080261900004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Mutation%20analysis%20and%20molecular%20genetics%20of%20epidermolysis%20bullosa&amp;author=L%20Pulkkinen&amp;author=J%20Uitto&amp;publication_year=1999&amp;journal=Matrix%20Biol&amp;volume=18&amp;pages=29-42">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(3)</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-99.11.868.3"
                             data-doi="10.1101/gad.9.15.1896">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fassler</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Meyer</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Consequences of lack of beta 1 integrin gene expression in mice</span>. <abbr class="cit-jnl-abbrev">Genes Dev</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">1896</span>-<span class="cit-lpage">908</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=genesdev&amp;resid=9/15/1896"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(4)</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-99.11.868.4"
                             data-doi="10.1016/S0960-9822(98)70402-6">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Georges-Labouesse</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mark</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Messaddeq</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gansmuller</span>  <span class="cit-name-given-names">A</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Essential role of alpha 6 integrins in cortical and retinal lamination</span>. <abbr class="cit-jnl-abbrev">Curr Biol</abbr> <span class="cit-pub-date">1998</span>;<span class="cit-vol">8</span>:<span class="cit-fpage">983</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0960-9822(98)70402-6&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9742403&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000075717100023&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Essential%20role%20of%20alpha%206%20integrins%20in%20cortical%20and%20retinal%20lamination&amp;author=E%20Georges-Labouesse&amp;author=M%20Mark&amp;author=N%20Messaddeq&amp;author=A%20Gansmuller&amp;publication_year=1998&amp;journal=Curr%20Biol&amp;volume=8&amp;pages=983-6">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(5)</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-99.11.868.5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kreidberg</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Donovan</span>  <span class="cit-name-given-names">MJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Goldstein</span>  <span class="cit-name-given-names">SL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rennke</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shepherd</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jones</span>  <span class="cit-name-given-names">RC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis</span>. <abbr class="cit-jnl-abbrev">Development</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">122</span>:<span class="cit-fpage">3537</span>-<span class="cit-lpage">47</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=develop&amp;resid=122/11/3537"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(6)</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-99.11.868.6">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">McHugh</span>  <span class="cit-name-given-names">KP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hodivala-Dilke</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zheng</span>  <span class="cit-name-given-names">MH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Namba</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lam</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Novack</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts</span>. <abbr class="cit-jnl-abbrev">J Clin Invest</abbr> <span class="cit-pub-date">2000</span>;<span class="cit-vol">105</span>:<span class="cit-fpage">433</span>-<span class="cit-lpage">40</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10683372&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000085446700006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Mice%20lacking%20beta3%20integrins%20are%20osteosclerotic%20because%20of%20dysfunctional%20osteoclasts&amp;author=KP%20McHugh&amp;author=K%20Hodivala-Dilke&amp;author=MH%20Zheng&amp;author=N%20Namba&amp;author=J%20Lam&amp;author=D%20Novack&amp;publication_year=2000&amp;journal=J%20Clin%20Invest&amp;volume=105&amp;pages=433-40">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(7)</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference (7) in text"
                           id="ref-7">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.7"
                             data-doi="10.1083/jcb.143.3.849">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Taverna</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Disatnik</span>  <span class="cit-name-given-names">MH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rayburn</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bronson</span>  <span class="cit-name-given-names">RT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yang</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rando</span>  <span class="cit-name-given-names">TA</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Dystrophic muscle in mice chimeric for expression of alpha5 integrin</span>. <abbr class="cit-jnl-abbrev">J Cell Biol</abbr> <span class="cit-pub-date">1998</span>;<span class="cit-vol">143</span>:<span class="cit-fpage">849</span>-<span class="cit-lpage">59</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jcb&amp;resid=143/3/849"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(8)</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference (8) in text"
                           id="ref-8">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.8"
                             data-doi="10.1093/emboj/19.15.3990">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brakebusch</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Grose</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Quondamatteo</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ramirez</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jorcano</span>  <span class="cit-name-given-names">JL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pirro</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Skin and hair follicle integrity is crucially dependent on beta 1 integrin expression on keratinocytes</span>. <abbr class="cit-jnl-abbrev">Embo J</abbr> <span class="cit-pub-date">2000</span>;<span class="cit-vol">19</span>:<span class="cit-fpage">3990</span>-<span class="cit-lpage">4003</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1093/emboj/19.15.3990&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10921880&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000088681800015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Skin%20and%20hair%20follicle%20integrity%20is%20crucially%20dependent%20on%20beta%201%20integrin%20expression%20on%20keratinocytes&amp;author=C%20Brakebusch&amp;author=R%20Grose&amp;author=F%20Quondamatteo&amp;author=A%20Ramirez&amp;author=JL%20Jorcano&amp;author=A%20Pirro&amp;publication_year=2000&amp;journal=Embo%20J&amp;volume=19&amp;pages=3990-4003">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(9)</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-99.11.868.9">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Werner</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Willem</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jones</span>  <span class="cit-name-given-names">LL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kreutzberg</span>  <span class="cit-name-given-names">GW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mayer</span>  <span class="cit-name-given-names">U</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Raivich</span>  <span class="cit-name-given-names">G</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Impaired axonal regeneration in alpha7 integrin-deficient mice</span>. <abbr class="cit-jnl-abbrev">J Neurosci</abbr> <span class="cit-pub-date">2000</span>;<span class="cit-vol">20</span>:<span class="cit-fpage">1822</span>-<span class="cit-lpage">30</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jneuro&amp;resid=20/5/1822"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(10)</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference (10) in text"
                           id="ref-10">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.10">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mayer</span>  <span class="cit-name-given-names">U</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Saher</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fassler</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bornemann</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Echtermeyer</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">von der Mark</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Absence of integrin alpha 7 causes a novel form of muscular dystrophy</span>. <abbr class="cit-jnl-abbrev">Nat Genet</abbr> <span class="cit-pub-date">1997</span>;<span class="cit-vol">17</span>:<span class="cit-fpage">318</span>-<span class="cit-lpage">23</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=9354797&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1997YD66700027&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Absence%20of%20integrin%20alpha%207%20causes%20a%20novel%20form%20of%20muscular%20dystrophy&amp;author=U%20Mayer&amp;author=G%20Saher&amp;author=R%20Fassler&amp;author=A%20Bornemann&amp;author=F%20Echtermeyer&amp;author=H%20von%20der%20Mark&amp;publication_year=1997&amp;journal=Nat%20Genet&amp;volume=17&amp;pages=318-23">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(11)</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-99.11.868.11">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Basani</span>  <span class="cit-name-given-names">RB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">French</span>  <span class="cit-name-given-names">DL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vilaire</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brown</span>  <span class="cit-name-given-names">DL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chen</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Coller</span>  <span class="cit-name-given-names">BS</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3</span>. <abbr class="cit-jnl-abbrev">Blood</abbr> <span class="cit-pub-date">2000</span>;<span class="cit-vol">95</span>:<span class="cit-fpage">180</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=bloodjournal&amp;resid=95/1/180"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(12)</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference (12) in text"
                           id="ref-12">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.12"
                             data-doi="10.1038/ng0298-94">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hayashi</span>  <span class="cit-name-given-names">YK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chou</span>  <span class="cit-name-given-names">FL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Engvall</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ogawa</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Matsuda</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hirabayashi</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Mutations in the integrin alpha7 gene cause congenital myopathy</span>. <abbr class="cit-jnl-abbrev">Nat Genet</abbr> <span class="cit-pub-date">1998</span>;<span class="cit-vol">19</span>:<span class="cit-fpage">94</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/ng0298-94&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9590299&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000073346700027&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Mutations%20in%20the%20integrin%20alpha7%20gene%20cause%20congenital%20myopathy&amp;author=YK%20Hayashi&amp;author=FL%20Chou&amp;author=E%20Engvall&amp;author=M%20Ogawa&amp;author=C%20Matsuda&amp;author=S%20Hirabayashi&amp;publication_year=1998&amp;journal=Nat%20Genet&amp;volume=19&amp;pages=94-7">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(13)</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference (13) in text"
                           id="ref-13">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.13"
                             data-doi="10.1002/dvdy.20462">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Flintoff-Dye</span>  <span class="cit-name-given-names">NL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Welser</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rooney</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Scowen</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tamowski</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hatton</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Role for the alpha7beta1 integrin in vascular development and integrity</span>. <abbr class="cit-jnl-abbrev">Dev Dyn</abbr> <span class="cit-pub-date">2005</span>;<span class="cit-vol">234</span>:<span class="cit-fpage">11</span>-<span class="cit-lpage">21</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/dvdy.20462&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16003770&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000231353700002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Role%20for%20the%20alpha7beta1%20integrin%20in%20vascular%20development%20and%20integrity&amp;author=NL%20Flintoff-Dye&amp;author=J%20Welser&amp;author=J%20Rooney&amp;author=P%20Scowen&amp;author=S%20Tamowski&amp;author=W%20Hatton&amp;publication_year=2005&amp;journal=Dev%20Dyn&amp;volume=234&amp;pages=11-21">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(14)</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference (14) in text"
                           id="ref-14">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.14"
                             data-doi="10.1074/jbc.271.4.2071">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Echtermeyer</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schober</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Poschl</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">von der Mark</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">von der Mark</span>  <span class="cit-name-given-names">K</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Specific induction of cell motility on laminin by alpha 7 integrin</span>. <abbr class="cit-jnl-abbrev">J Biol Chem</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">271</span>:<span class="cit-fpage">2071</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=271/4/2071"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(15)</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference (15) in text"
                           id="ref-15">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.15">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">LaTulippe</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Satagopan</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Scher</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Scardino</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Reuter</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic
                                    disease</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">2002</span>;<span class="cit-vol">62</span>:<span class="cit-fpage">4499</span>-<span class="cit-lpage">506</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=62/15/4499"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(16)</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference (16) in text"
                           id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.16"
                             data-doi="10.1002/mc.10018">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Luo</span>  <span class="cit-name-given-names">JH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">YP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cieply</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lin</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Deflavia</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dhir</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Gene expression analysis of prostate cancers</span>. <abbr class="cit-jnl-abbrev">Mol Carcinog</abbr> <span class="cit-pub-date">2002</span>;<span class="cit-vol">33</span>:<span class="cit-fpage">25</span>-<span class="cit-lpage">35</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/mc.10018&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=11807955&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000173276900004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Gene%20expression%20analysis%20of%20prostate%20cancers&amp;author=JH%20Luo&amp;author=YP%20Yu&amp;author=K%20Cieply&amp;author=F%20Lin&amp;author=P%20Deflavia&amp;author=R%20Dhir&amp;publication_year=2002&amp;journal=Mol%20Carcinog&amp;volume=33&amp;pages=25-35">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(17)</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference (17) in text"
                           id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.17"
                             data-doi="10.1200/JCO.2004.05.158">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">YP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Landsittel</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jing</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nelson</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ren</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Liu</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">2004</span>;<span class="cit-vol">22</span>:<span class="cit-fpage">2790</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=22/14/2790"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(18)</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference (18) in text"
                           id="ref-18">↵</a><div class="cit ref-cit ref-book" id="cit-99.11.868.18">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rice</span>  <span class="cit-name-given-names">J</span></span></li>
                              </ol><cite>. <span class="cit-source">Mathematical statistics and data analysis</span>. <span class="cit-publ-loc">Pacific Grove (CA)</span>: <span class="cit-publ-name">Duxbury Press</span>; <span class="cit-pub-date">2006</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Mathematical%20statistics%20and%20data%20analysis&amp;author=J%20Rice&amp;publication_year=2006">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(19)</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference (19) in text"
                           id="ref-19">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.19"
                             data-doi="10.1038/sj.onc.1209134">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ren</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tseng</span>  <span class="cit-name-given-names">GC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cieply</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gavel</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nelson</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">MCM7 amplification and overexpression are associated with prostate cancer progression</span>. <abbr class="cit-jnl-abbrev">Oncogene</abbr> <span class="cit-pub-date">2006</span>;<span class="cit-vol">25</span>:<span class="cit-fpage">1090</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/sj.onc.1209134&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16247466&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000235361000013&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=MCM7%20amplification%20and%20overexpression%20are%20associated%20with%20prostate%20cancer%20progression&amp;author=B%20Ren&amp;author=G%20Yu&amp;author=GC%20Tseng&amp;author=K%20Cieply&amp;author=T%20Gavel&amp;author=J%20Nelson&amp;publication_year=2006&amp;journal=Oncogene&amp;volume=25&amp;pages=1090-8">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(20)</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference (20) in text"
                           id="ref-20">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.20">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jing</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Liu</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">YP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dhir</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Acquafondada</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Landsittel</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of myopodin induces suppression of tumor growth and metastasis</span>. <abbr class="cit-jnl-abbrev">Am J Pathol</abbr> <span class="cit-pub-date">2004</span>;<span class="cit-vol">164</span>:<span class="cit-fpage">1799</span>-<span class="cit-lpage">806</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=15111326&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000221042800031&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20myopodin%20induces%20suppression%20of%20tumor%20growth%20and%20metastasis&amp;author=L%20Jing&amp;author=L%20Liu&amp;author=YP%20Yu&amp;author=R%20Dhir&amp;author=M%20Acquafondada&amp;author=D%20Landsittel&amp;publication_year=2004&amp;journal=Am%20J%20Pathol&amp;volume=164&amp;pages=1799-806">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(21)</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference (21) in text"
                           id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.21"
                             data-doi="10.1158/0008-5472.CAN-06-0227">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">YP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Luo</span>  <span class="cit-name-given-names">JH</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">2006</span>;<span class="cit-vol">66</span>:<span class="cit-fpage">7414</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=66/15/7414"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(22)</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference (22) in text"
                           id="ref-22">↵</a><div class="cit ref-cit ref-book" id="cit-99.11.868.22">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hosmer</span>  <span class="cit-name-given-names">DW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lemeshow</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>. <span class="cit-source">Applied survival analysis</span>. <span class="cit-publ-loc">Hoboken (NJ)</span>: <span class="cit-publ-name">Wiley</span>; <span class="cit-pub-date">2003</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Applied%20survival%20analysis&amp;author=DW%20Hosmer&amp;author=S%20Lemeshow&amp;publication_year=2003">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(23)</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference (23) in text"
                           id="ref-23">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.23"
                             data-doi="10.1016/S0046-8177(03)00014-5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ren</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">YP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jing</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Liu</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Michalopoulos</span>  <span class="cit-name-given-names">GK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Luo</span>  <span class="cit-name-given-names">JH</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Gene expression analysis of human soft tissue leiomyosarcomas</span>. <abbr class="cit-jnl-abbrev">Hum Pathol</abbr> <span class="cit-pub-date">2003</span>;<span class="cit-vol">34</span>:<span class="cit-fpage">549</span>-<span class="cit-lpage">58</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0046-8177(03)00014-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12827608&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000183677600011&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Gene%20expression%20analysis%20of%20human%20soft%20tissue%20leiomyosarcomas&amp;author=B%20Ren&amp;author=YP%20Yu&amp;author=L%20Jing&amp;author=L%20Liu&amp;author=GK%20Michalopoulos&amp;author=JH%20Luo&amp;publication_year=2003&amp;journal=Hum%20Pathol&amp;volume=34&amp;pages=549-58">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(24)</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference (24) in text"
                           id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.24"
                             data-doi="10.1016/0092-8674(93)90498-F">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gyuris</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Golemis</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chertkov</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brent</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2</span>. <abbr class="cit-jnl-abbrev">Cell</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">75</span>:<span class="cit-fpage">791</span>-<span class="cit-lpage">803</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0092-8674(93)90498-F&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8242750&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993MH74900023&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Cdi1%2C%20a%20human%20G1%20and%20S%20phase%20protein%20phosphatase%20that%20associates%20with%20Cdk2&amp;author=J%20Gyuris&amp;author=E%20Golemis&amp;author=H%20Chertkov&amp;author=R%20Brent&amp;publication_year=1993&amp;journal=Cell&amp;volume=75&amp;pages=791-803">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(25)</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference (25) in text"
                           id="ref-25">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.25"
                             data-doi="10.1073/pnas.91.5.1731">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hannon</span>  <span class="cit-name-given-names">GJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Casso</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beach</span>  <span class="cit-name-given-names">DKAP</span></span></li>
                              </ol><cite>. <span class="cit-article-title">a dual specificity phosphatase that interacts with cyclin-dependent kinases</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci U S A</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">91</span>:<span class="cit-fpage">1731</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=91/5/1731"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">(26)</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference (26) in text"
                           id="ref-26">↵</a><div class="cit ref-cit ref-journal" id="cit-99.11.868.26">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kawashima</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hirose</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Satoh</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaneko</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ikeda</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaziro</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">MgcRacGAP is involved in the control of growth and differentiation of hematopoietic cells</span>. <abbr class="cit-jnl-abbrev">Blood</abbr> <span class="cit-pub-date">2000</span>;<span class="cit-vol">96</span>:<span class="cit-fpage">2116</span>-<span class="cit-lpage">24</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=bloodjournal&amp;resid=96/6/2116"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div>
            <div id="related">
               <h2>Related articles</h2>
               <ul class="related-list">
                  <div class="cit">
                     <div class="cit-metadata"><span class="cit-first-element cit-section">IN THIS ISSUE<span class="cit-sep cit-sep-after-article-section">:</span> </span><span class="cit-title">IN THIS ISSUE </span> <cite><abbr title="Journal of the National Cancer Institute" class="site-title">JNCI J Natl Cancer Inst</abbr> <span class="cit-print-date"><span class="cit-sep cit-sep-before-article-print-date">(</span>2007<span class="cit-sep cit-sep-after-article-print-date">)</span> </span><span class="cit-vol">99 </span><span class="cit-issue"><span class="cit-sep cit-sep-before-article-issue">(</span>11<span class="cit-sep cit-sep-after-article-issue">):</span> </span><span class="cit-pages"><span class="cit-first-page">825</span> </span><span class="cit-doi"><span class="cit-sep cit-sep-before-article-doi"> doi:</span>10.1093/jnci/djk225 </span><span class="cit-online-date"><span class="cit-sep cit-sep-before-article-online-date">First published online </span>June 5, 2007 </span></cite>  
                     </div>
                     <div class="cit-extra"><span class="accesscheck jnci;99/11/825 pdf_extract,full,reprint"></span> 
                        <ul class="cit-views">
                           <li class="first-item"><a href="/content/99/11/825.1.extract" rel="extract">Extract</a></li>
                           <li><a href="/content/99/11/825.1.full" rel="full-text">Full Text (HTML)</a></li>
                           <li><a href="/content/99/11/825.1.full.pdf+html" rel="full-text.pdf">Full Text (PDF)</a></li>
                           <li class="last-item"><a href="/content/99/11/825.1/suppl/DC1" rel="supplemental-data"
                                 class="dslink-japanese-translation">Japanese Translation</a></li>
                        </ul>  
                     </div> 
                  </div>
               </ul>
            </div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/99/11/858.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/99/11/881.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/99/11.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="open-access-note">
               <span class="open-access-note">OPEN ACCESS</span>
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="JNCI Journal of the National Cancer Institute" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">JNCI J Natl Cancer Inst</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">
                                    (2007) 
                                    </span>
                                 
                                 <span class="slug-vol">
                                    99
                                    </span><span class="slug-issue">
                                    (11):
                                    </span><span class="slug-pages">
                                    868-880.
                                    </span>
                                 <span class="slug-doi-wrapper">
                                    
                                    doi:
                                    
                                    <span title="10.1093/jnci/djk199" class="slug-doi">10.1093/jnci/djk199</span>
                                    </span>
                                 </cite>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li><span class="creative-commons-article">This article is Open Access<span>OA</span></span></li>
                        <li><span class=""></span></li>
                        <li class="abstract-view-link primary"><a href="/content/99/11/868.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/99/11/868.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                        <li><a href="/content/99/11/868/suppl/DC1" rel="supplemental-data"
                              class="dslink-supplementary-data">Supplementary Data</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=ARTICLES&amp;sortspec=date&amp;submit=Submit">Article</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="/articleusage?gca=jnci;99/11/868" rel="nofollow">Article metrics</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jnci%3B99%2F11%2F868&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/99/11/868.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=99/11/868&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/99/11/868.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="/search?qbe=jnci%3B99%2F11%2F868&amp;citation=Ren%20et%20al.%2099%20%2811%29:%20868&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=jnci%3B99%2F11%2F868&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=17551147&amp;link_type=MED_NBRS"
                              class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jnci%3B99%2F11%2F868">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=jnci%3B99%2F11%2F868">Download citation</a></li>
                        <li><a class="request-permissions"
                              href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jnci&amp;title=Analysis%20of%20Integrin%20%CE%B17%20Mutations%20in%20Prostate%20Cancer%2C%20Liver%20Cancer%2C%20Glioblastoma%20Multiforme%2C%20and%20Leiomyosarcoma%3A%20&amp;publicationDate=06%2F06%2F2007&amp;author=Baoguo%20Ren%2C%20Yan%20P.%20Yu%2C%20George%20C.%20Tseng%2C%20Chuanyue%20Wu%2C%20Ka%20Chen%2C%20Uma%20N.%20Rao%2C%20Joel%20Nelson%2C%20George%20K.%20Michalopoulos%2C%20Jian-Hua%20Luo&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjnci%2Fdjk199&amp;volumeNum=99&amp;issueNum=11&amp;startPage=868&amp;endPage=880&amp;orderBeanReset=true"
                              target="_blank">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/99/11/868.full?cited-by=yes&amp;legid=jnci;99/11/868#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/99/11/868" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/scopus-links/jnci/99/11/868?access_num=/jnci/99/11/868"
                              rel="external-nw"
                              id="cb-scopus-citing-articles">Citing articles via Scopus</a></li>
                        <li><a href="/external-ref?access_num=%2Fjnci%2F99%2F11%2F868&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                        <li><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/99/11/868.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ARen%20author%3AB.%22"
                              class="cb-art-gs-auth author-link">Articles by  Ren, B.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ALuo%20author%3AJ.H.%22"
                              class="cb-art-gs-auth author-link">Articles by  Luo, J. H.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/99/11/868.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=17551147&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Ren%20B&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Ren, B.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Yu%20YP&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Yu, Y. P.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Tseng%20GC&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Tseng, G. C.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Wu%20C&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Wu, C.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Chen%20K&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Chen, K.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Rao%20UN&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Rao, U. N.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Nelson%20J&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Nelson, J.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Michalopoulos%20GK&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Michalopoulos, G. K.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Luo%20JH&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Luo, J. H.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="#related">Related articles in this journal</a></li>
                        <li><a href="/content/99/11/868.full?related-urls=yes&amp;legid=jnci;99/11/868#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Share</span></h4>
                     <ol>
                        <li><a href="/email?gca=jnci%3B99%2F11%2F868&amp;current-view-path=/content/99/11/868.full">
                              Email this article</a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/99/11/868&amp;title=Analysis%20of%20Integrin%20%CE%B17%20Mutations%20in%20Prostate%20Cancer%2C%20Liver%20Cancer%2C%20Glioblastoma%20Multiforme%2C%20and%20Leiomyosarcoma+--+Ren%20et%20al.%2099%20%2811%29%3A%20868+--+Journal%20of%20the%20National%20Cancer%20Institute&amp;doi=10.1093/jnci/djk199&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/99/11/868&amp;title=Analysis%20of%20Integrin%20%CE%B17%20Mutations%20in%20Prostate%20Cancer%2C%20Liver%20Cancer%2C%20Glioblastoma%20Multiforme%2C%20and%20Leiomyosarcoma+--+Ren%20et%20al.%2099%20%2811%29%3A%20868+--+Journal%20of%20the%20National%20Cancer%20Institute&amp;doi=10.1093/jnci/djk199&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/short/99/11/868&amp;title=Analysis%20of%20Integrin%20%CE%B17%20Mutations%20in%20Prostate%20Cancer%2C%20Liver%20Cancer%2C%20Glioblastoma%20Multiforme%2C%20and%20Leiomyosarcoma+--+Ren%20et%20al.%2099%20%2811%29%3A%20868+--+Journal%20of%20the%20National%20Cancer%20Institute&amp;doi=10.1093/jnci/djk199&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/99/11/868&amp;title=Analysis%20of%20Integrin%20%CE%B17%20Mutations%20in%20Prostate%20Cancer%2C%20Liver%20Cancer%2C%20Glioblastoma%20Multiforme%2C%20and%20Leiomyosarcoma+--+Ren%20et%20al.%2099%20%2811%29%3A%20868+--+Journal%20of%20the%20National%20Cancer%20Institute&amp;doi=10.1093/jnci/djk199&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/99/11/868&amp;title=Analysis%20of%20Integrin%20%CE%B17%20Mutations%20in%20Prostate%20Cancer%2C%20Liver%20Cancer%2C%20Glioblastoma%20Multiforme%2C%20and%20Leiomyosarcoma+--+Ren%20et%20al.%2099%20%2811%29%3A%20868+--+Journal%20of%20the%20National%20Cancer%20Institute&amp;doi=10.1093/jnci/djk199&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/99/11/868&amp;title=Analysis%20of%20Integrin%20%CE%B17%20Mutations%20in%20Prostate%20Cancer%2C%20Liver%20Cancer%2C%20Glioblastoma%20Multiforme%2C%20and%20Leiomyosarcoma+--+Ren%20et%20al.%2099%20%2811%29%3A%20868+--+Journal%20of%20the%20National%20Cancer%20Institute&amp;doi=10.1093/jnci/djk199&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-11">Patients, Materials, and Methods</a></li>
                        <li><a href="#sec-26">Results</a></li>
                        <li><a href="#sec-28">Discussion</a></li>
                        <li><a href="#fn-group-1">Footnotes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" type="text" name="fulltext" id="header-qs-input" />
                     <input type="hidden" name="submit" value="yes" />
                     
                     <input class="inline_button" type="image" alt="Go" src="/publisher/img/buttons/go.gif" />
                     
                     <div class="adv-search-link"><a href="/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="/content/current"><span>
                                 		  <span class="current-issue-date">
                                    October 2015
                                    </span><span class="toc-citation-volume">
                                    
                                    107
                                    </span><span class="toc-citation-issue">(10)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="/content/current"><img src="/content/107/10.cover.gif" alt="JNCI J Natl Cancer Inst" id="cover" /></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1"
                          src="/resource/htmlfiles/advert.html?p=Right1&amp;u=jnci.oxfordjournals.org/content/99/11/868.full"
                          width="0"
                          height="0"
                          frameborder="0"
                          scrolling="no"
                          class="resize_ad"></iframe>
                  
               </div>
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/about.html" rel=""
                              title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/contact_us.html" rel=""
                              title="Contact Us">Contact Us</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html"
                              rel=""
                              title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="HTTP://www.oxfordjournals.org/access_purchase/dispatch_dates.html#JNCI.JP"
                              rel=""
                              title="Dispatch date of next issue">Dispatch date of next issue</a>
                           
                        </li>
                        <li>
                           <a href="http://publicationethics.org/" rel=""
                              title="This journal is a member of the Committee on Publication Ethics (COPE)">This journal is a member of the Committee on Publication Ethics (COPE)</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" rel=""
                              title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                        <li>
                           <a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;t732=469986&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102"
                              rel=""
                              title="Journals Career Network">Journals Career Network</a>
                           
                        </li>
                     </ul>
                     
                     <p>
                        <a href="http://www.oxfordjournals.org/our_journals/jnci/episodes_2012.html">
                           <img alt="Podcast Logo" style="float:left"
                                src="http://www.oxfordjournals.org/podcasts/podcast_icon_35x35.gif" />JNCI Podcast</a>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Connect with us!</h3>
                     <a href="https://twitter.com/JNCI_Now">
                        <img class="small_margin" alt="Connect with us on Twitter!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/connect_twitter.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     <a href="https://www.facebook.com/thejnci">
                        <img class="small_margin" alt="Connect with us on Facebook!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/facebook.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     
                     <p>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <p>Carmen J. Allegra</p>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/editorial_board.html"
                              rel=""
                              title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor: 12.583</h3>
                     
                     <h3 class="five_year">5-Yr impact factor: 13.584</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>For the Media</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/press_room.html" rel=""
                              title="JNCI PRESS ROOM">JNCI PRESS ROOM</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html"
                              rel=""
                              title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html"
                              rel=""
                              title="Self Archiving/Public Access Policy">Self Archiving/Public Access Policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/ ">
                        <img alt="Open access options for authors - visit Oxford Open"
                             src="http://www.oxfordjournals.org/resource/image/promos/oxford_open_small.gif" />
                        </a>
                     <a href="http://www.oxfordjournals.org/oxfordopen/funder_policies/">
                        <img alt="RCUK Wellcome Trust Open Access"
                             src="http://www.oxfordjournals.org/resource/image/wellcome-trust-180x100.jpg" />
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="http://www.oxfordjournals.org/resource/image/pmc-logo.gif" />
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" rel=""
                              title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jnci.oxfordjournals.org/help/citetrack/index.dtl" rel=""
                              title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="/rss" rel="" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" rel=""
                              title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" rel=""
                              title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/classifiedadinprint.html"
                              rel=""
                              title="Classified Advertising">Classified Advertising</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300"];</script>
               </div>
            
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/6/443?rss=1&amp;ssource=mfr">Breast Density and Cancer Risk: What Is the Relationship?</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/9/713?rss=1&amp;ssource=mfr">The Female Prostate</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/91/14/1194?rss=1&amp;ssource=mfr">Tobacco Smoke Carcinogens and Lung Cancer</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/107/6/djv048?rss=1&amp;ssource=mfr">Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity,
                                 Poverty, and State</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/105/23/1799?rss=1&amp;ssource=mfr">Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study</a></li>
                        </ol>
                        	    <a href="http://jnci.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/3/205?rss=1&amp;ssource=mfc">New Guidelines to Evaluate the Response to Treatment in Solid Tumors</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/18/1371?rss=1&amp;ssource=mfc">Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/85/5/365?rss=1&amp;ssource=mfc">The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International
                                 Clinical Trials in Oncology</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/13/1107?rss=1&amp;ssource=mfc">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/1/4?rss=1&amp;ssource=mfc">What Is the Evidence That Tumors Are Angiogenesis Dependent?</a></li>
                        </ol>
                        	  <a href="http://jnci.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom"
                    src="/resource/htmlfiles/advert.html?p=Bottom&amp;u=jnci.oxfordjournals.org/content/99/11/868.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2105 - Print ISSN 0027-8874</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a> 
               <span>2015</span> Oxford University Press
               
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input type="image" src="/resource/image/buttons/go.gif" alt="Go"
                            class="inline_button" />
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript"
                 src="http://gab.cookie.oup.com/aws-cookie/oup.cookiepolicy.pack.js"
                 defer="defer"></script>
         
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jquery-ui.min.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jcarousellite.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/pf_oiunderbarinit.js"
                 type="text/javascript"></script>
         <script defer="defer" src="/resource/js/underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">
    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <noscript><img src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" height="1" width="1"
                 border="0"
                 hspace="0"
                 vspace="0"
                 alt="" /></noscript><script type="text/javascript" src="//ouptag.scholarlyiq.com/ntpagetag.js"></script><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   </body>
</html>